10-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended September 30, 2014

OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from Not Applicable to Not Applicable

Commission file number: 0-147

HICKOK INCORPORATED

(Exact name of registrant as specified in its charter)

Ohio	34-0288470
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
10514 Dupont Avenue, Cleveland, Ohio	44108
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number (216) 541-8060

Securities registered pursuant to

Section 12(b) of the Act:
NONE
Securities registered pursuant to Section 12(g) of the Act:

Class A Common Shares, without par value
(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined by Rule 405 of the Securities Act. Yes [ ] No [X]

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes [ ] No [X]

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K(229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer,""accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]
Non-accelerated filer   [ ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [ ] No [X]

As of March 31, 2014 the Registrant had 1,163,349 voting shares of Class A Common Stock outstanding and 474,866 voting shares of Class B Common Stock outstanding. As of such date, non-affiliates held 641,405 shares of Class A Common Stock and 85,056 shares of Class B Common Stock. As of March 31, 2014, based on the closing price of $2.34 per Class A Common Share on the Over The Counter Bulletin Board, the aggregate market value of the Class A Common Stock held by such non-affiliates was approximately $1,500,888. There is no trading market in the shares of Class B Common Stock.

As of January 2, 2015, 1,163,349 shares of Class A Common Stock and 474,866 shares of Class B Common Stock were outstanding.

Documents Incorporated by Reference:

PART OF FORM 10-K	DOCUMENT INCORPORATED BY REFERENCE
Part III (Items 10, 11, 12, 13 and 14)	Portions of the Registrant's Definitive Proxy Statement to be used in connection with its Annual Meeting of Shareholders to be held on February 25, 2015.

Except as otherwise stated, the information contained in this Form 10-K is as of September 30, 2014.

Table of Contents

PART I.
ITEM 1. BUSINESS
ITEM 1A. RISK FACTORS
ITEM 1B. UNRESOLVED STAFF COMMENTS
ITEM 2. PROPERTIES
ITEM 3. LEGAL PROCEEDINGS
ITEM 4. MINE SAFETY DISCLOSURES
ITEM 4A. EXECUTIVE OFFICERS OF REGISTRANT



PART II.
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
ITEM 6. SELECTED FINANCIAL DATA
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
ITEM 9A. CONTROLS AND PROCEDURES
ITEM 9B. OTHER INFORMATION
F-1: REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
F-2: CONSOLIDATED BALANCE SHEET
F-3: CONSOLIDATED LIABILITIES AND STOCKHOLDERS' EQUITY
F-4: CONSOLIDATED STATEMENT OF INCOME
F-5: CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
F-6: CONSOLIDATED STATEMENT OF CASH FLOWS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. NATURE OF OPERATIONS 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3. NOTES RECEIVABLE
4. CONVERTIBLE NOTES PAYABLE
5. SHORT-TERM FINANCING
6. LEASES
7. STOCK OPTIONS
8. CAPITAL STOCK, TREASURY STOCK, AND CONTRIBUTED CAPITAL
9. INCOME TAXES
10. EARNINGS PER COMMON SHARE
11. EMPLOYEE BENEFIT PLANS
12. SEGMENT AND RELATED INFORMATION
13. COMMITMENTS AND CONTINGENCIES
14. SUBSEQUENT EVENTS
15. BUSINESS CONDITION AND MANAGEMENT PLAN
16. QUARTERLY DATA (UNAUDITED)

PART III.
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
ITEM 11. EXECUTIVE COMPENSATION
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES


PART IV.

SIGNATURES
EXHIBIT INDEX
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AS TO CONSOLIDATED SCHEDULES
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

PART I

ITEM 1. BUSINESS.

General Development of Business

Hickok Incorporated was founded in 1910 and organized in 1915 as an Ohio corporation, and first offered its securities to the public in 1959. Except as otherwise stated, the terms "Company" or "Hickok" as used herein mean Hickok Incorporated and its two wholly-owned subsidiaries, Supreme Electronics LLC and Waekon LLC. Hickok develops and manufactures products used by companies in the transportation industry. Primary markets served are automotive, emissions testing, aircraft, and locomotive with sales both to original equipment manufacturers (OEMs) and to the aftermarkets.

The Company's Internet address is http://www.hickok-inc.com. Hickok makes available free of charge on or through its website its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 12(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after the Company electronically files such materials with, or furnishes it to, the Securities and Exchange Commission (the "SEC"). The SEC maintains an Internet site that contains these reports at www.sec.gov.

The Company was founded producing D’Arsonval indicators and continues to manufacture these products today. The current Indicator product line is focused on highly reliable specialized indicators used in the cockpits of certain aircraft, locomotives, and transit vehicles. It is a stable line of business with few competitors in the market. The indicator business represents approximately 24% of the Company’s revenue.

Until the mid 1980s, Hickok was known primarily for its ability to develop and manufacture electronic instruments for electronic servicers, precision indicating instruments for aircraft, locomotive, and industrial applications, and electronic teaching systems for vocational schools. For the past twenty-seven years the Company has used this expertise to develop and manufacture electronic diagnostic tools and equipment used by automotive technicians in the automotive service market. This is now the Company's largest business segment. The Company generated approximately 76% of its fiscal 2014 revenue from designing and manufacturing diagnostic tools for automotive diagnostics and testing. These tools enable service technicians to identify problems in both electronic systems and other non-electronic systems in automobiles and trucks.

Nineteen years ago, two large automotive OEM companies comprised over 80% of the Company's business. A substantial portion of this business was contingent on large programs initiated by these OEMs on a year-to-year basis. The Company recognized that OEMs were changing and that the likelihood of the continuation of these yearly large programs was diminishing. Recognizing that customer diversification was desirable and that much of the technology that had been developed for OEMs could have application to the non-dealer service market (known as the aftermarket), the Company added new products, customers and an established aftermarket sales channel with the acquisition of Waekon Industries in 1998. As a result, the Company executed a strategy to use this existing technical and manufacturing expertise and to develop sales and marketing skills applicable to the automotive aftermarket service industry. The Company uses Waekon, Hickok, and Hickok/Waekon as the brands of its products that are primarily marketed to aftermarket service organizations.

The Company continues to develop aftermarket service tools and in recent years has successfully cultivated relationships with Tier 1 OEM service tool suppliers as well. The Company has increased its revenue from these customers in the past several years and now puts as much emphasis on this market segment as it does with respect to tools for the aftermarket. Most of these tools are branded to the Tier 1 supplier’s requirements. These tools tend to be more complex than typical aftermarket tools, but the technology developed often has application to subsequent aftermarket products.

The Company's operations are currently concentrated in the United States of America. Sales are primarily to domestic customers, although the Company also makes sales to international customers through domestically based distribution companies.

Operating Segment Information

The Company's operations are combined into two reportable business segments: 1) indicators and gauges and 2) automotive diagnostic tools and equipment. Reference is made to "Segment and Related Information" included in the notes to the financial statements.

Indicators and Gauges

For over one hundred years the Company has developed and manufactured precision indicating instruments used in aircraft, locomotives and other applications. In recent years the Company has specialized in aircraft and locomotive cockpit instruments. Within the aircraft market, instruments are sold primarily to manufacturers or servicers of business, military, and pleasure aircraft. Within the locomotive market, indicators are sold to both original equipment manufacturers and to operators of railroad equipment. Indicators and gauges represented approximately 24% of the Company's sales for fiscal 2014 and 26% for fiscal 2013. A number of the Company's aircraft instruments are FAA certified and a number of others are type certified with aircraft manufacturers. A significant revenue source within this segment is for high reliability ruggedized movements used on certain military aircraft. However, these products are subject to federal government funding of military programs and can vary significantly from year to year.

Although the Company does not view this segment as having a high growth potential, it does contribute significant revenues and margins. The Company believes year to year variation of revenue is more dependent on customer timing than any general market direction.

Automotive Diagnostic Tools and Equipment

The Company has concentrated on designing and marketing instruments used to diagnose automotive electronic systems. These products were initially sold to one OEM but are now sold to several automotive OEMs through Tier 1 suppliers, and to the aftermarket using jobbers, wholesalers and mobile distributors. Sales of products designed specifically to OEM requirements have been balanced with products developed for automotive aftermarket servicers and the emissions testing industry. The aftermarket accounted for approximately 22% of the Company's automotive diagnostic and specialty tool sales in fiscal 2014 and 26% for fiscal 2013. As a whole, automotive diagnostic tools and equipment represented approximately 76% of the Company's sales for fiscal 2014 and 74% for fiscal 2013. The percentage increase was due primarily to higher OEM sales in fiscal 2014 compared to fiscal 2013.

The Company's primary expertise is electronic measurement of physical properties and it has cultivated a reputation for developing innovative tools for automotive diagnostics. The Company uses this reputation as leverage when it introduces new offerings. Our recent focus on tools for automotive technicians results in low cost tools that are easy to use, save technicians time, and improve diagnostic accuracy. OEM tools tend to be tools that are sophisticated and allow the technician diagnostic access to vehicle systems that are otherwise inaccessible for the technician to pinpoint the vehicle’s issue.  An example of this is the Active Fuel Injector Tester ("AFIT"), which the Company introduced several years ago to General Motors dealers.

In 2009, at the OEM’s request, we developed accessory interfaces that allow the same level of ability to diagnose fuel injection system issues for Diesel engines and the recently introduced Gasoline Direct Injection ("GDI") engines. General Motors decided to equip their North American dealers with technology to diagnose fuel issues on their GDI engines and the Company furnished over 3,800 adapters to the AFIT Tester during fiscal 2014. General Motors has also inquired about the technology for a global tool to address the GDI engines and the Company is currently preparing a proposal for global use based on the technology developed for North American dealers. In addition to General Motors, the Company produces several testers for use on Chrysler and John Deere products as well as several other OEMs that are also sold through Tier 1 suppliers. Furthermore, an OEM has expressed interest in three of our aftermarket products as possible tools required in their dealerships and we have several active proposals with Tier 1 suppliers for products they have expressed interest in for their customers.

Over the past four years, we have updated essentially all our aftermarket products and recently introduced a unique product that economically offers a service person the capabilities of an oscilloscope to view waveforms, but with the simple operation of a digital camera. Introduced in September 2014, the response to this product, to date has been exceptional. Our plan is to continue to develop products for automotive service, and at least four new products are currently expected to be introduced during fiscal 2015. The new products and the improved economy are resulting in increased sales activity and revenues on all the recent introductions. Unfortunately, two older products sold in the aftermarket that were originally OEM tools (NGS products) and were large revenue generators for the Company in the past have been declining in sales, resulting in only small apparent increases in our aftermarket sales. Such older products no longer represent significant revenue to us and the actual growth in aftermarket sales of newer products should be evident in the future.

Aftermarket sales channels are always changing and 2014 was no exception. The most effective way to introduce new products has been to grant a major distributor an exclusive right to purchase and market for an initial period during introduction because they historically put a great emphasis on the product for the exclusivity period. Three of the products the Company introduced to the automotive aftermarket this past year followed this concept. Unfortunately, all three of these distributors underwent upheavals during the period of our product introduction and the emphasis we expected did not materialize. Late in fiscal 2014, the products were taken to the general distribution channels and all three are starting to build the customer acceptance we expected much earlier in the year. The Company’s plan is to continue to develop new and unique products for the automotive aftermarket and likely we will continue to use the exclusive distributor introduction strategy.

During 2014, our sales and marketing team have upgraded our internet sites and capabilities immensely. The Company introduced a subscription program for the NGS PC product that required developing the infrastructure and expertise necessary for an internet store. We believe many of our automotive aftermarket products with minor adaptations are attractive tools for many service technicians outside the automotive industry. Our current distribution channels are relatively concentrated in the automotive market, however, we have been successful in having a number of our products incorporated on the internet sites of Home Depot and Amazon and many of our sales through these channels have been to non-automotive service customers.

The Company is planning to expand our offerings to these non-automotive customers using the Internet as the initial sales channel. We are extensively using social media, video demonstration, and e-mail advertising to reach customers. To date these efforts have been to customers in automotive service but we intend to expand these techniques to other industries. In addition, during fiscal 2014 we completed the upgrade of our MIS system to the latest capability and began a major upgrade to the Company's IT infrastructure, both hardware and software. The Company's IT infrastructure upgrade is anticipated to be completed in fiscal 2015. Our plan is to continue this emphasis to further improve our presence in the electronic market places.
 
Emissions testing products for gas caps and gas tanks were a major revenue contributor for the Company for a number of years as new state testing programs were implemented. Despite very few state programs being implemented in recent years, we continue to enjoy a base level of business for these products as replacements and as new stations join the various state programs. In 2013, the only competing manufacturer of gas cap testers announced that it was discontinuing the manufacture and service of their gas cap testers. Thereafter we briefly enjoyed increased business in replacement testers and expected that this increased business to continue into 2014, but it did not. In addition, we continue to sell small quantities of our gas tank tester to service stations in California.

Sources and Availability of Raw Materials

Raw materials essential to the business are acquired from a large number of United States of America manufacturers and some materials are now purchased from European and Southeast Asian sources. Materials acquired from the electronic components industry include transistors, integrated circuits, resistors, capacitors, switches, potentiometers, micro controllers, and other passive parts. Fabricated metal or plastic parts are generally purchased from local suppliers or manufactured by the Company from raw materials. In general, the required materials are available, if ordered with sufficient lead times, from multiple sources at current prices.

Importance of Patents, Licenses, Franchises, Trademarks and Concessions

The Company presently has several patents that relate to several of its products. The Company believes that its position in the industry is dependent upon its present level of engineering skill, research, sales relationships, production techniques and service. However, the Company does have several basic methodology patents related to products it offers that it considers very important to future revenue. Of the Company's most critical patents, one is related to the testing of evaporative emissions systems that was the basis for the Company's product offering for the State of California. This patent expires in the year 2022. Another critical patent is related to vehicle fuel cap testing which expires in 2018. The Company monitors the marketplace for infringement of its patents and intends to pursue its rights should an infringement take place. The Company is currently engaged in such a proceeding. See Item 3 Legal Proceedings. Other than the names "Hickok" and "Waekon", the Company does not have any material licenses, trademarks, franchises or concessions.

Seasonality

The Company believes that there is a seasonality to the automotive aftermarket revenues. Typically the first and fourth quarters tend to be weaker than the other two quarters in this market. Orders for OEM or emissions testing products are primarily subject to customer timing requirements and have no known seasonality aspect to them. As a result, operating results can fluctuate widely from quarter to quarter and year to year.

Practices Relative to Working Capital Items

The nature of the Company's business requires it to maintain sufficient levels of inventory to meet rapid delivery requirements of customers. The Company provides its customers with payment terms prevalent in the industry.

Dependence on Single or Few Customers

Several aftermarket distribution companies and several equipment OEMs have become significant sources of revenue for the Company. Sales in fiscal 2014 to Bosch, a Tier 1 supplier to numerous OEMs, amounted to approximately $2,768,000 or 44% of the consolidated sales of the Company, sales to Snap-On amounted to approximately $341,000 or 5% of the consolidated sales of the Company and sales to Electro-Motive amounted to approximately $284,000 or 4% of the consolidated sales of the Company. In fiscal 2013 sales to Bosch amounted to approximately $2,304,000 or 36% of the consolidated sales of the Company, sales to General Electric amounted to approximately $651,000 or 10% of the consolidated sales of the Company and sales to Opus Inspection, Inc. amounted to approximately $242,000 or 4% of the consolidated sales of the Company. Sales to Bosch amounted to approximately $905,000 or 19% of the consolidated sales of the Company, sales to General Electric amounted to approximately $710,000 or 15% of the consolidated sales of the Company and sales to Opus Inspection, Inc. amounted to approximately $229,000 or 5% of the consolidated sales of the Company during fiscal 2012. The Company does not have exclusive supply agreements or long-term contractual relationships with these large customers.

Backlog

The Company's order backlog as of September 30, 2014 totaled $539,000 as compared to $631,000 as of September 30, 2013 and $707,000 as of September 30, 2012. The decrease in fiscal 2014 versus 2013 was due to decreased orders for indicators and gauges of approximately $215,000. In addition, automotive diagnostic products orders to OEM's increased by approximately $102,000 and $24,000 for emission products, offset by a decrease of $3,000 for non-emission aftermarket products. The decrease in fiscal 2013 versus 2012 was due to decreased orders for indicators and gauges of approximately $36,000. In addition, automotive diagnostic products orders to OEM's decreased by approximately $56,000 and $2,000 for emission products, offset by an increase of $18,000 for non-emission aftermarket products.

Government Contract Renegotiation

No major portion of the business is open to renegotiation of profits or termination of contracts or subcontracts at the election of the United States Government. The amount of revenue derived from government contracts is currently minimal and not material.

Competitive Conditions

The Company is engaged in a highly competitive industry and faces competition from domestic and international firms. Several of the Company's competitors have greater financial resources and larger sales organizations than the Company. Competition with respect to the Company's diagnostic tool business arises from the existence of a number of other significant manufacturers in the field, such as Bosch and Snap-On, which dominate the available market in terms of total sales. The instrumentation industry is composed primarily of companies that specialize in the production of particular items as compared to a full line of instruments. The Company believes that its competitive position in this field is in the area of smaller, specialized products, an area in which the Company has operated and in which the Company has established itself competitively by offering high-quality, high-performance products in comparison to high-volume, mass-produced items.

The Company depends on the automotive industry for sales of its OEM and aftermarket products. The Company's results of operations were adversely affected by the deterioration in the automotive industry's performance during the fiscal 2012 and 2011 years, as well as poor economic conditions throughout the country. The Company anticipates that it will continue to face significant challenges due to competition, however markets appear to be continuing to improve. The two markets are driven by different considerations. The OEM market tends to be driven by the need for new tools due to the introduction of new technologies in vehicles or excessive warranty costs. Because of dealership economics, OEMs are  reluctant to require dealers to purchase service tools. The aftermarket is largely driven by the economics of fixing vehicles. During poor economic times, purchases can be delayed. Although aftermarket parts suppliers have done well during the past few years, aftermarket tool suppliers have not. Our strategy of developing products that target the technician and low cost tools for shop use is an outgrowth of these realities in the marketplace. We believe substantial opportunities for growth depends primarily on the introduction of new and innovative products to the sectors we service.

In addition to automotive service products, the Company diversified some years ago into the emissions testing market. This market has also been depressed partially because EPA requirements for state emissions testing program requirements have changed and partially because state budgets have not allowed the implementation of new testing programs. The Company briefly experienced improved sales of emissions products in part due to the discontinuance of certain emissions products by a competitor and we expect the market to remain at historical levels.

Research and Development Activities

The Company expensed as incurred product development costs of $965,975 in 2014, $939,373 in 2013 and $938,058 in 2012. These expenditures included engineering product support and development of manuals for both of the Company's business segments.

Compliance with Environmental Provisions

The Company's capital expenditures, earnings and competitive position are not materially affected by compliance with federal, state and local environmental provisions which have been enacted or adopted to regulate the distribution of materials into the environment.

Number of Persons Employed

Total employment by the Company at September 30, 2014 was 87 full-time employees which represents a 10% increase from 79 employees in fiscal 2013 and a 14% increase from 76 employees in fiscal 2012. The Company has no part-time employees. None of the employees are represented by a union. The Company considers its relations with its employees to be good.

Financial Information Concerning Foreign and Domestic Operations and Export Sales

During the fiscal year ended September 30, 2014, all manufacturing, research and development and administrative operations were conducted in the United States of America. Revenues derived from export sales approximated $156,000 in 2014, $148,000 in 2013, and $163,000 in 2012. Shipments to Australia, Canada, Mexico and Taiwan make up the majority of export sales.

ITEM 1A. RISK FACTORS.

Not Applicable.

ITEM 1B. UNRESOLVED STAFF COMMENTS.

Not Applicable.

ITEM 2. PROPERTIES.

As of December 17, 2014 the Company had facilities in the United States of America as shown below:

LOCATION	SIZE	DESCRIPTION	OWNED OR LEASED
Cleveland, Ohio	37,000 Sq. Ft.	Two-story brick construction; used for corporate administrative headquarters, marketing and product development with limited manufacturing.	Owned
Greenwood, Mississippi	63,000 Sq. Ft.	One-story modern concrete block construction; used for manufacturing instruments, test equipment, and fastening systems products.	Leased, with annual renewal options extending through 2061.

The Company believes its plants and offices are in satisfactory operating condition, well maintained, adequate for the uses to which they are put and are adequately insured. Both of the Company's business segments utilize these properties.

ITEM 3. LEGAL PROCEEDINGS.

The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market (Hickok Incorporated v. Systech International, LLC and Delphi Corporation) currently pending in the United States District Court for the Northern District of Ohio. The suit alleges infringement by the defendants on two of the Company's emission product patents. On one patent, which is related to gas cap testing, there were multiple items sold by Systech International, LLC in several markets over a period of several years. On the second patent, which relates to the Company's method for evaporative emissions testing used in California, there were multiple items sold into the California market during 2007 by Systech International, LLC and Delphi Corporation. The suit against Systech International, LLC was filed in the United States District Court for the Northern District of Ohio Eastern Division on November 16, 2007 alleging the gas cap testing infringement. In January 2008 infringement of the Company's evaporative emissions patent was added to the suit. The current status is that all expert opinions and depositions have been filed with the court and the suit is proceeding to stages leading up to the trial phase but no trial date has been set. The Company is seeking damages estimated at approximately $299,000 for the gas cap testing patent infringement and approximately $3,148,000 for the evaporative emissions testing patent infringement.

Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the Company's results of operations, financial position or cash flows.  

ITEM 4. MINE SAFETY DISCLOSURES.

Not Applicable.

ITEM 4A. EXECUTIVE OFFICERS OF REGISTRANT.*

The following is a list of the executive officers of the Company as of September 30, 2014. The executive officers are elected each year and serve at the pleasure of the Board of Directors. Mr. Robert Bauman was elected Chairman by the Board of Directors in July 1993 and served as chairman until May 2001. He has been President since 1991 and Chief Executive Officer since 1993. The Board of Directors elected Mr. Gregory Zoloty Vice President of Finance and Chief Financial Officer in May 2001. Mr. Zoloty was Vice President of Accounting and Chief Accounting Officer since 1994. He joined the Company in 1986. Mr. James Allen was elected Vice President of Manufacturing by the Board of Directors in March 2012. Mr. Allen was elected Vice President of Production Engineering in February 2009. He joined the Company in August 1979. Mr. George Hart was elected Vice President of Engineering by the Board of Directors in February 2004. He joined the Company in April 1985. Mr. Patrick Bauman was elected Vice President Sales and Marketing by the Board of Directors in March 2012. Mr. Patrick Bauman was elected Vice President Distribution Sales and Marketing by the Board of Directors in February 2010. Mr. Patrick Bauman is the son of Mr. Robert Bauman. He joined the Company in December 1995.

OFFICE	OFFICER	AGE
President and Chief Executive Officer	Robert L. Bauman	74
Vice President, Finance and Chief Financial Officer	Gregory M. Zoloty	62
Vice President, Manufacturing	James F. Allen	52
Vice President, Sales and Marketing	Patrick R. Bauman	44
Vice President, Engineering	George R. Hart	57

*The description of Executive Officers called for in this Item is included pursuant to Instruction 3 to Section (b) of Item 401 of Regulation S-K.

PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

a) MARKET INFORMATION

During fiscal 2014 our Class A Common Shares were traded on The Over-The Counter Bulletin Board Market under the symbol HICKA.QB. There is no market for the Registrant's Class B Common Shares.

The following table sets forth the per share range of high and low bids (Over-The-Counter Bulletin Board) for the Registrant's Class A Common Shares for the periods indicated. The Over-The-Counter Bulletin Board prices reflect inter-dealer prices without retail markup, markdown or commissions and may not represent actual transactions. Data was supplied by Nasdaq.

PRICES FOR THE YEARS ENDED:
	September 30, 2014			September 30, 2013
		HIGH	LOW	HIGH	LOW
First Quarter		2.05	1.25	2.50	1.10
Second Quarter		2.62	1.50	2.10	1.60
Third Quarter		2.34	1.50	2.10	1.02
Fourth Quarter		2.28	1.41	2.10	1.10

b) HOLDERS

As of January 2, 2015, there were approximately 184 shareholders of record of the Company's outstanding Class A Common Shares and 5 holders of record of the Company's outstanding Class B Common Shares.

c) DIVIDENDS

In fiscal 2014, 2013 and 2012 the Company paid no dividends on either of its Class A or Class B Common Shares. Pursuant to the Company's Amended Articles of Incorporation, no dividends may be paid on Class B Common Shares until cash dividends of ten cents per share per fiscal year are paid on Class A Common Shares. Any determination to pay cash dividends in the future will be at the discretion of the Board of Directors after taking into account various factors, including the Company's financial condition, results of operations and current and anticipated cash needs.

ITEM 6. SELECTED FINANCIAL DATA.

FOR THE YEARS ENDED SEPTEMBER 30

	2014			2013		2012		2011			2010
	(In Thousands of Dollars, except per share amounts)
Net Sales	$		6,306	$	6,466	$	4,761	$	5,069		$	5,259
Net Income (Loss)	$		8	$	139	$	(784)	$	(673)		$	(949)
Working Capital	$		2,809	$	2,442	$	1,936	$	2,447		$	2,784
Total Assets	$		3,700	$	3,505	$	3,206	$	3,441		$	3,809
Long-term Debt	$	435		$	-0-	$	-0-	$	250		$	-0-
Total Stockholders' Equity	$	2,759		$	2,748	$	2,318	$	2,621		$	3,281
Net Income (Loss) Per Share	$		.01	$	.09	$	(.57)	$	(.54)		$	(.76)
Dividends Declared
Per Share:
Class A	$		-0-	$	-0-	$	-0-	$		-0-	$	-0-
Class B	$		-0-	$	-0-	$	-0-	$		-0-	$	-0-
Stockholders' Equity
Per Share:	$		1.68	$	1.68	$	1.52		2.10		$		2.63
Return on Sales	.1%			2.1%		(16.5%)		(13.3%)			(18.1%)
Return on Assets	.2%			4.1%		(23.6%)		(18.6%)			(22.3%)
Return on Equity	.3%			5.5%		(31.7%)		(22.8%)			(25.3%)
Closing Stock Price	$		2.11	$	2.04	$	1.25	$	1.80		$	4.25

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Introduction

The Company has been focused on tools for automotive servicers for about 30 years. Initially, tools developed for OEM dealership technicians were essentially all the Company’s offerings and in the late 1990s over 80% of the Company’s automotive business was concentrated in tools for two OEM dealerships. In the late 1990s the Company perceived a change in OEM policies that was of concern relative to future business expectations. In 1998 the Company acquired Waekon Industries, an automotive aftermarket business, that expanded the Company's sales channels and product offering in the aftermarket markets, and the Company began to emphasize diversification into these markets. In addition, the Company began to offer several of the tools developed for OEMs to the aftermarket. One in particular, the NGS scan tool for Ford vehicles, became extremely successful and represented a substantial part of aftermarket sales until recently. In 2008, Ford began offering their replacement for NGS to the aftermarket and the Company's NGS sales began to decline. Although other aftermarket tools developed by the Company were a growing revenue source the decline in NGS sales resulted in a net decline in aftermarket sales.

As a outgrowth of the Waekon acquisition, the Company also developed several unique devices for use in vehicle emissions testing programs mandated by the Environmental Protection Agency and applied for patent protection. In the intervening years, the Company continued to receive large orders for OEM tools and the emissions testing products that caused aftermarket sales to remain less than 50% of total automotive product sales. In fiscal 2014, approximately 22% of the Company’s automotive diagnostic tool revenue was from aftermarket customers and 78% was from OEM and emissions customers. The lower percentage in 2014 was due primarily to a large OEM order obtained and delivered in fiscal 2014. Aftermarket revenue declined to $1,051,000 from approximately $1,199,000 in fiscal 2013 largely as a result of the elimination of non-profitable products and declining NGS product sales. In fiscal 2012, approximately 43% or $1,327,000 of the Company’s automotive diagnostic tool revenue was from aftermarket customers and 57% was from OEM and emissions customers.
 
During the past several years, the Company has eliminated a number of unprofitable aftermarket products, re-developed and re-introduced a number of older products, and introduced at least three new aftermarket products per year. In addition, the Company renewed its’ emphasis on OEMs as a revenue source, but focused on working with the Tier 1 suppliers. This focus on the Tier 1 suppliers has resulted in large orders in both 2014 and 2013 and also a significant increase in smaller order business for other tools used by the OEM dealerships. Emissions products have largely become a replacement business that is sold through automotive aftermarket distribution channels, but there still may be occasional opportunities for larger orders as certain states expand emissions testing programs. The net result is that the automotive business distinction between aftermarket, OEM, and emissions has become less clear, but the Company’s expertise applies to each of these automotive markets. In 2014, automotive products were 76% of the Company’s revenue and management believes there is a significant opportunity for growth in these products.

The Company has changed its strategy related to OEM customers. In the past, we often developed a product and modified it to a specific OEM’s requirements after interesting them in its value. The Company has been cultivating a relationship with the Tier I supplier to most North American OEMs. We have achieved a preferred supplier status with this supplier and currently produce a number of products used by various OEMs. We have been able to grow this business approximately 30% in 2012, and 160% in 2013 due to a large order for Breakout Box, and 25% in 2014 due in large part to an order for an accessory to our AFIT tool delivered in 2008 that expands its’ capability to gasoline direct injection engines, as well as an increase in small orders for new and previously supplied tools. We are continuing to cultivate our relationship with an additional Tier 1 Tool Supplier to other OEM's. Our plan is to continue to target opportunities to develop and manufacture OEM tools with all Tier 1 suppliers.

The Company has offered products for government sponsored emissions testing programs for a number of years.  The Company also developed a product to test for leaks in vehicle evaporative systems (gas tanks). The Company has patents for both of these technologies and is currently involved in a lawsuit with a company that we believe infringed on our patents for these products. Sales of these products in prior years resulted in revenues that ranged from several hundred thousand dollars to over $6,900,000 in fiscal 2008. Most new emissions testing programs emphasize OBD II testing and the U.S. Environmental Protection Agency allows minimal credit for testing either gas caps or gas tanks on those vehicles. However, there is still a need for replacement products and equipment for new installations requiring cap or tank testing that provides a significant revenue source for the Company. In fiscal 2014, revenue for these products was approximately $615,000 compared to $936,000 in fiscal 2013. In early fiscal 2013, the only competitor for gas cap testing equipment for state programs announced it was leaving the business and significant 2013 emission sales resulted from sales of our products to distribution as replacements for theirs. In 2014, there was no similar “pipeline fill” sales. We expect the market for emission products to continue at the 2014 level.

Development efforts for fiscal 2012 were concentrated on developing lower cost aftermarket products targeted at automotive service technicians as personal tools. The aftermarket revenue was declining rapidly because NGS product sales that had been a large revenue source was declining. We were able to reverse the trend but only slightly since NGS product was such a significant element of the revenue. Since NGS has reached such a low revenue level, the effect of the past three years new product developments should become evident in increased automotive aftermarket sales going forward. In both 2013 and 2014, we split our development efforts between aftermarket and OEM. In 2013, we discontinued a number of non-profitable aftermarket products. The result was a decrease in aftermarket revenues but an increase in margin. In 2014, we continued to split development efforts and introduced four new products to the aftermarket and supported the manufacture of a large OEM order and several smaller OEM orders. One of the products introduced in September 2014 called AutoWave is expected to be a major revenue contributor in fiscal 2015 and we are hoping to interest OEMs in its’ capability.

During fiscal 2014, we delivered a large order to OEM dealers for a tool that tests the fuel injection system on gasoline direct injection vehicles. That same OEM expressed an interest in a global tool to do the same job. We have prepared a proposal for them using the technology we believe only Hickok possesses. In addition we have a number of proposals for products before several OEMs using our proprietary technologies that the Tier 1 supplier has told us are of interest to the OEM.  We continue to believe that there is a large opportunity for OEM business working with the Tier 1 suppliers that service essentially all North American vehicle manufacturers and there is substantial current activity in this product segment.
   
Sales and Marketing has completely revamped the Company’s internet website that supports product sales. The team expanded our use of social media and videos to explain the benefits of our products. Also, we have developed the technology and infrastructure for a web store that is initially being used for subscription sales of NGS PC software in an effort to revitalize NGS revenues. The team has also recognized that a number of our automotive products have utility for service technicians in many other industries that our current distribution channels do not reach. In fiscal 2015, the Company plans on expanding our markets through the use of these new capabilities available to us. Increased emphasis on new products and efforts by our sales staff has had a noticeable effect on our relationships with the automotive aftermarket distribution channels and Tier 1 suppliers. We feel our relationships are stronger now in both channels than they have been in the past seven years.

The Company has placed a major emphasis on expansion of our use of the Internet and other electronic media to sell our products, increase customer contact and awareness, and improve operations. We are offering a few products for sale direct to customers through electronic media and directing customers to our distributors for products sold through distribution. We intend to expand the direct product offerings to customers outside our traditional automotive servicers. In addition, we have sales and training videos on nearly all of our newer products that can be viewed by customers on their computers. The Company plans to continue the emphasis on expansion of the use of electronic media in fiscal 2015.

The timing of order releases and large program implementations in the Company's automotive diagnostic equipment business can cause wide fluctuations in the Company's operating results, both on a quarter-to-quarter and a year-to-year basis. Orders for such equipment can be large, are subject to customer schedules, and may result in substantial variations in quarterly and yearly sales and earnings. For example, the first and second quarters of fiscal 2013 benefited from a large order with a Tier 1 supplier to an OEM. In fiscal 2014, the third and fourth quarters benefited from a large order for an OEM. In fiscal 2011 and 2012, there were no such large opportunities.

The Company’s indicator product revenue decreased 10% in fiscal 2014 and its percentage of total Company revenues decreased to 24% from 26% in fiscal 2013. The year to year decrease was primarily a result of decreased customer orders of government funded programs for the military. The Company’s indicator product revenue increased 3% in fiscal 2013 and its percentage of total Company revenues decreased to 26% from 34% in fiscal 2012. The year to year increase was primarily a result of increased customer orders. The percentage decrease was because automotive sales increased due to a large OEM order. The Company anticipates indicator sales will continue at current levels in fiscal 2015 and into the foreseeable future. Management feels that resources dedicated to this segment are adequate at the present time.

Looking forward, the introduction of new automotive diagnostic products to the aftermarket and Tier 1 suppliers on a regular basis is very important for the growth of the automotive related diagnostic tools and equipment business segment. Management implemented steps to reduce expenses in early fiscal 2009 due to the economic downturn and uncertainty in the markets the Company serves. These reductions included rate reductions for all employees. Additional personnel reductions were implemented during fiscal 2011 and a strategy to develop and market lower cost products directed primarily to technicians was also implemented. The cutbacks slowed the new product development process, however, the Company has taken precautions to maintain its technologies. Management believes the current resources are sufficient to develop aftermarket products and to react to any large opportunities that may result from our emphasis on the Tier I Suppliers to OEMs. Management plans to continue tight control of expenses in marketing, engineering, administrative and sales, and related expenses until revenue will support adding additional resources.

Expense Control

Management continues to monitor its expense reduction initiatives implemented and revised from 2008 to 2011. During fiscal 2013 and 2012, management developed a plan that included a limited increase in personnel and a small increase in the compensation of existing personnel. The changes were intended to accelerate both the introduction of new products and to enhance the sales of existing products through improved market presence and promotion. Management believes its strategy to improve revenue and profitability aided results in fiscal 2014 and 2013 and will continue to aid results during fiscal 2015. The Company currently has no plans to add resources in fiscal 2015 unless revenue opportunities warrant such an increase.

Reportable Segment Information

The Company is required to report segment information disclosures based on how management evaluates operating performance and resource allocations. The Company has determined that it has two reportable segments: 1) indicators and gauges, and 2) automotive related diagnostic tools and equipment.

Indicators and Gauges

This segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business, military and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to original equipment manufacturers, servicers of locomotives, and operators of railroad equipment.

Automotive Diagnostic Tools and Equipment

This segment consists primarily of products designed and manufactured to support the testing or servicing of automotive and truck systems using electronic means to measure vehicle parameters. These products are sold to OEMs and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions.

Results of Operations

Sales for the fiscal year ended September 30, 2014 decreased to $6,305,836, a decrease of approximately 3% from fiscal 2013 sales of $6,466,172. This decrease in sales was volume-driven and attributable primarily to lower product sales of approximately $112,000. Service sales in fiscal 2014 decreased by approximately $48,000 compared to fiscal 2013 due to volume. Product sales were $6,078,349 in fiscal 2014 compared to $6,190,260 in fiscal 2013. The decrease in product sales occurred in the indicator and gauge segment. Within the automotive diagnostic products, OEM products sales increased approximately $504,000 offset by a decrease in emissions products and aftermarket products of approximately $321,000 and $148,000 respectively. Sales of indicator products decreased in fiscal 2014 by approximately $147,000 and was volume related due primarily to decreased military movement orders. Both fiscal 2014 and 2013 benefited from a large order from a Tier 1 Supplier to a large OEM. The reduction in service sales was volume related and attributable to lower repair sales.

Sales for the fiscal year ended September 30, 2013 increased to $6,466,172, an increase of approximately 36% from fiscal 2012 sales of $4,761,289. This increase in sales was volume-driven and attributable primarily to higher product sales of approximately $1,748,000. Service sales in fiscal 2013 decreased by approximately $43,000 compared to fiscal 2012 due to volume. Product sales were $6,190,260 in fiscal 2013 compared to $4,442,133 in fiscal 2012. The increase in product sales occurred in both the automotive diagnostic equipment segment and the indicator and gauge segment. Within the automotive diagnostic products, OEM products and emission products sales increased approximately $1,437,000 and $381,000 respectively offset by a decrease in aftermarket products of approximately $128,000. Sales of indicator products increased in fiscal 2013 by approximately $58,000 and was volume related due primarily to increased military movement orders. Fiscal 2013 benefited from a large order from a Tier 1 Supplier to a large OEM with no similar order in fiscal 2012. In addition, fiscal 2013 benefited from increased gas cap tester sales of approximately $300,000 due to the exit from the market of our only competitor in gas cap testing testers. The reduction in service sales was volume related and attributable to lower repair sales.

Cost of products sold in fiscal 2014 was $3,462,092 or 57.0% of net product sales compared to $3,359,727 or 54.3% of net product sales in fiscal 2013. Cost of products sold during fiscal 2012 was $2,787,212 or 62.7% of net product sales. The dollar and percentage increase in the cost of products sold to product sales between fiscal 2014 and 2013 was due primarily to product mix and cost specifics of the products sold. The dollar increase in the cost of products sold to product sales between fiscal 2013 and 2012 was due primarily to the increase in sales volume. The percentage decrease was due to a change in product mix.

Cost of services sold in fiscal 2014 was $149,068 or 65.5% of net service sales compared to $138,307 or 50.1% respectively in fiscal 2013. Cost of services sold during fiscal 2012 was $216,949 or 68.0% of net service sales. The dollar and percentage increase between fiscal 2014 and 2013 was due primarily to product specific technical issues of the chargeable repairs in fiscal 2014. The dollar and percentage decrease between fiscal 2013 and 2012 was due primarily to price adjustments, lower costs and the elimination of certain products for chargeable repairs.

Product development expenditures in fiscal 2014 were $965,975 or 15.9% of product sales compared to $939,373 or 15.2%, respectively, in fiscal 2013. Product development expenditures during fiscal 2012 were $938,058 or 21.1% of product sales. The percentage increase between fiscal 2014 and fiscal 2013 was due primarily to the decrease in sales volume during fiscal 2014. The dollar increase was primarily in labor costs and research and experimental material of approximately $19,000 and $9,000 respectively. The percentage decrease between fiscal 2013 and fiscal 2012 was due primarily to the increase in sales volume during fiscal 2013. The dollar increase was primarily in research and experimental material expense and labor costs of approximately $3,000 and $1,000 respectively, offset in part by a decrease in travel expenses of $3,000. Management believes current resources will be sufficient to maintain current product development commitments and to continue to develop a reasonable flow of new diagnostic products for both the OEM and aftermarket customers.

Marketing and administrative expenses amounted to $1,728,107 which was 27.4% of net sales in fiscal 2014, $1,812,598 or 28.0% of net sales in fiscal 2013 and $1,616,320 or 33.9% of net sales in fiscal 2012. The dollar decrease in fiscal 2014 compared to fiscal 2013 was due to decreases in both marketing and administrative expenses. Marketing expenses were approximately $712,000 in fiscal 2014 compared to $761,000 a year ago. Within marketing expenses, decreases were primarily in commissions of $50,000, advertising of $14,000, promotion expense of $5,000, collection expense of $5,000 and outside consulting of $4,000. The decreases were offset in part by an increase in royalty expense of $15,000 and labor costs of $12,000. Administrative expenses were approximately $1,017,000 during the current fiscal year compared to $1,052,000 a year ago. The dollar decrease was due primarily to decreases in professional fees of $19,000, rent machinery and equipment of $10,000, depreciation expense of $8,000, data processing fees of $4,000, travel expense of $3,000 and repairs and maintenance costs of $2,000. The decreases were offset in part by an increase in labor costs of $18,000.

The percentage decrease in marketing and administrative expenses in fiscal 2013 compared to fiscal 2012 was due to the higher sales volume in fiscal 2013. The dollar increase in fiscal 2013 compared to fiscal 2012 was due to increases in both marketing and administrative expenses. Marketing expenses were approximately $761,000 in fiscal 2013 compared to $626,000 in fiscal 2012. Within marketing expenses, increases were primarily in royalty expense of $48,000, commissions of $44,000, labor costs of $24,000, advertising of $12,000, promotion expense of $5,000 and collection expense of $1,000. The increases were offset in part by a decrease in outside consulting of $3,000. Administrative expenses were approximately $1,052,000 during fiscal 2013 compared to $990,000 in fiscal 2012. The dollar increase was due primarily to increases in professional fees of $99,000, data processing fees of $7,000 and travel expense of $2,000. The increases were offset in part by a decrease in rent machinery and equipment of $14,000, depreciation of $12,000, repairs and maintenance costs of $6,000, directors fees of $4,000 and labor costs of $3,000.

Interest charges were $6,592 in fiscal 2014 compared with $91,178 in fiscal 2013 and $5,956 in fiscal 2012. The current year interest expense is primarily due to the recording of interest expense on the short-term demand notes of approximately $6,364. The decrease in interest charges in fiscal 2014 compared to fiscal 2013 was due primarily to recording as non-cash interest expense the present value of warrants issued in December 2012 with no similar charges in fiscal 2014. The increase in interest charges in fiscal 2013 compared to fiscal 2012 was due primarily to recording as non-cash interest expense the present value of warrants issued in December 2012. The current convertible note payable with one of the Company's major shareholders, who is also a director of the Company, is available through December 30, 2014.

Other income was $14,374 in fiscal 2014 compared with $13,816 in fiscal 2013 and $19,240 in fiscal 2012. Other income consists primarily of interest income on cash and cash equivalents and proceeds from the sale of scrap metal shavings. The increase in fiscal 2014 compared to fiscal 2013 was due primarily to to an increase in the sale of scrap metal shavings of approximately $5,000 offset by a decrease in interest income of approximately $4,000. The decrease in interest income in fiscal 2014 was due to a lower level of cash and cash equivalents available for investment. The decrease in fiscal 2013 compared to fiscal 2012 was due primarily to a decrease in the sale of scrap metal shavings of approximately $5,000 offset by an increase in interest income of approximately $3,000. In addition, fiscal 2013 did not have a gain on sale of fixed assets compared to the fiscal 2012 gain of $4,000. The increase in interest income in fiscal 2013 was due to higher level of cash and cash equivalents available for investment. Currently, excess cash is invested in a money market account.

Income taxes in fiscal 2014 were $0 which includes an increase in the valuation allowance on deferred income taxes of $44,400. In fiscal 2013 income taxes were $0 which included a decrease in the valuation allowance on deferred income taxes of $114,400. In fiscal year 2012 management recorded a valuation allowance in the amount of $187,400 on the current year deferred taxes. It is anticipated that the effective tax rate in fiscal 2015 will be similar to fiscal 2014. The expiration of the Company's net operating loss and research and development credit carryforwards could occur before they can be used. The deferred tax benefits begin to expire in fiscal 2016.

Net income in fiscal 2014 was $8,376, or $.01 per share as compared to the net income of $138,804, or $.09 per share in fiscal 2013. The decrease in  net income in fiscal 2014 was primarily due to a lower sales volume and lower product margins. The net income in fiscal 2013 was $138,805, or $.09 per share as compared to the net loss of $783,966 or $.59 per share in fiscal 2012. The improvement of approximately $923,000 in 2013 was due primarily to the increased sales volume attributed to the significant order from a Tier 1 supplier for an OEM. The net loss in fiscal 2012 was due primarily to a lower sales volume in 2012.

The Company has available a net operating loss carryforward of approximately $5,500,000 and research and development credit carryforwards of approximately $1,800,000 that begin to expire in fiscal 2016. The Company's entire deferred tax asset of $4,166,700 has been offset by a valuation allowance of $4,166,700. Because of the uncertainties involved with this significant estimate, it is reasonably possible that the Company's estimate may change.

Liquidity and Capital Resources

Current assets of $3,314,781 at September 30, 2014 were 6.6 times current liabilities and the total of cash and cash equivalents and receivables was 3.1 times current liabilities. These ratios compare to 4.2 and 2.1 respectively at the end of fiscal 2013. Cash and cash equivalents was $390,327 at September 30, 2014 and $938,852 at September 30, 2013. Total current assets increased by approximately $115,000 from the previous year end due primarily to an increase in accounts receivable, inventory and prepaid expenses of approximately $534,000, $124,000 and $6,000, respectively. The increases were offset by a decrease in cash and cash equivalents of approximately $549,000. The increase in accounts receivable was due primarily to an increase in the sales volume in the last quarter of the fiscal year 2014. Inventory increased due primarily to a decrease in the obsolescence reserve during the current year and the increase in prepaid expenses was due primarily to timing.

Working capital at September 30, 2014 was $2,809,348 as compared to $2,442,454 a year ago. The increase of approximately $367,000 was due primarily to an increase in accounts receivable, inventory and prepaid expenses of approximately $534,000, $124,000 and $6,000, respectively, by a decrease in cash and cash equivalents of approximately $549,000. In addition, there were decreases in accrued expenses, accounts payable and accrued payroll and related expense of approximately $217,000, $29,000, and $10,000, respectively. The increase in accounts receivable was due primarily to an increase in the sales volume in the last quarter of the fiscal year. The increase in inventory was due primarily to an decrease in the obsolescence reserve in the current year.

Internally generated funds in fiscal 2014 were a negative $606,811 and were not adequate to fund the Company's primary non-operating cash requirements consisting of capital expenditures of $141,714 consisting of tooling, machinery and equipment for product manufacturing and IT infrastructure. The primary reason for the negative cash flow from operations was the increase in accounts receivable and inventory of $535,952 and $124,381, respectively. Internally generated funds in fiscal 2013 were $685,922 and were adequate to fund the Company's primary non-operating cash requirements consisting of capital expenditures of $14,443 consisting of tooling and machining equipment for product manufacturing. The primary reason for the positive cash flow from operations in fiscal 2013 was the net income of $138,805, non-cash interest expense, non-cash depreciation, a reduction in accounts receivable, inventory and prepaid expenses, of $91,000, $64,186, $64,530, $144,954 and $91,615 respectively. In addition, accrued expenses increased by $89,083. Internally generated funds in fiscal 2012 were a negative $401,787. The primary reason for the negative cash flow from operations in fiscal 2012 was the net loss of $783,966. The Company anticipates approximately $110,000 of capital expenditures during fiscal 2015 primarily to complete the upgrade and replacement of the Company's IT infrastructure. The Company expects there will be internally generated funds in fiscal 2015 from operating activities in addition to probable available short-term or long-term financing, to provide adequate funding of the Company's working capital needs.

Whenever there may be a requirement to increase inventory in fiscal 2015, there will be a negative but temporary impact on liquidity. As previously noted, management implemented expense reductions in response to the economic downturn and uncertainty in the markets the Company serves. These expense reductions began in fiscal 2009 and have continued through fiscal 2014, and are anticipated to continue into fiscal 2015. The Company has reduced headcount, product development, and marketing, administrative and sales related expenses at points during this expense reduction program  in order to appropriately manage its working capital.

In December 2014, management entered into Amendment No. 3 of the Convertible Loan Agreement which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is between the Company and a major shareholder who is also a Director, as discussed in Note 4 to the Company's financial statements. This amended agreement modified the terms of the previously amended agreement by modifying the terms and extending the due date of the loan agreement from December 30, 2014 to December 30, 2015 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion. During fiscal 2014, the Company borrowed $200,000 against this facility and at September 30, 2014 this balance is outstanding.

During the third quarter of fiscal 2014, the Company entered into various short-term unsecured demand notes with Robert L. Bauman. The Company borrowed $683,400 to help meet the on going working capital requirements related to the large order received in January of 2014. The agreements were with a major shareholder who is also an employee of the Company as discussed in Note 5 to the Company's financial statements. The Company had no outstanding balance on the various short-term demand notes at September 30, 2014.

Discussions Regarding Potential Acquisition

The Company is engaged in discussions with First Francis Company, Inc., an entity affiliated with Edward F. Crawford and Matthew V. Crawford, directors of the Company, concerning a potential acquisition of Federal Hose LLC, a wholly owned subsidiary of First Francis. The Company has submitted a non-binding proposal letter to First Francis under the terms of which it would acquire all of the membership interests of Federal Hose in exchange for an aggregate of (i) 911,250 of the Company’s Class A Common Shares; (ii) 303,750 of the Company’s Class B Common Shares; and (iii) $4,268,662 in a note to be issued by the Company, which will rank pari passu with its existing indebtedness, bear interest at an annual rate of 4% payable quarterly, subject to redemption over a mandatory 10-year amortization schedule and required to be fully redeemed within six years of their issuance date.
 
Information concerning this prospective transaction constitutes forward-looking statements. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. With respect to statements relating to this proposed transaction, such uncertainties include, among other things, the fact that no agreement has been reached between the parties with respect to the terms of the proposed transaction, and the fact that any such transaction would be subject to a number of conditions precedent, including the negotiation of a satisfactory purchase agreement, authorization by the Board of Directors of the Company, receipt of third party consents, and the satisfaction of other customary conditions precedent. In addition, shareholder approval of the transaction may be required including, in the event that Class B Common Shares are proposed to be issued, separate approval of the holders of a majority of the Company’s Class A Shares. We cannot assure you that any agreement will be reached with respect to the transaction or as to the timing or terms thereof.

Business Condition and Uncertainties

Until the past two years, the Company suffered recurring losses from operations due primarily to decreasing sales of existing product lines and a general economic downturn in all markets the Company serves. The resulting lower sales levels have impacted the Company's accounts receivable and cash balances. If this situation were to continue, it could prevent the Company from generating sufficient cash flow to sustain its operations.

The ability of the Company to continue as a going concern is dependent on improving the Company's profitability and cash flow and securing additional financing if needed. Management continues to review and revise its strategic plan and believes in the viability of its strategy to increase revenues and profitability through increased sales of existing products and the introduction of new products to the marketplace. In addition, management took steps to reduce expenses described above under the caption "Expense Control" and continues to monitor expenses closely. In addition, subsequent to the end of fiscal 2012, the Company entered into the financing arrangements described above under the caption "Liquidity and Capital Resources". Management believes that the actions presently being taken by the Company will provide the stimulus for it to continue as a going concern, however, because of the inherent uncertainties there can be no assurances to that effect. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Off-Balance Sheet Arrangements

Hickok has no off-balance sheet arrangements (as defined in Regulation S-K Item 303 paragraph (a)(4)(ii)) that have or are reasonably likely to have a material current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

Critical Accounting Policies

The Company describes its significant accounting policies in the notes to the consolidated financial statements included in the Company's Annual Report on Form 10-K. However, in response to the SEC's Release No. FR-60, "Cautionary Advice Regarding Disclosure About Critical Accounting Policies", issued December 12, 2001, the Company has identified the policies it believes are most critical to an understanding of the Company's financial statements. Since application of these accounting policies involves the exercise of judgment and use of estimates, actual results could differ from those estimates.

Revenue Recognition - Revenue is recognized as manufactured items are shipped to customers, legal title has passed, and all significant contractual obligations of the Company have been satisfied. Revenue from development contracts is recorded as agreed upon milestones are achieved.

Inventory Valuation and Reserves - Inventories are valued at the lower of cost or market using the first-in, first-out (FIFO) method. The Company's business may require an increase in inventory of component parts, work-in-process and finished goods in order to meet anticipated delivery schedules of customers. However, the Company is responsible for excess and obsolete inventory purchases in excess of inventory needed to meet customer demand forecasts, as well as inventory purchases generally not covered by supply agreements, or parts that become obsolete before use in production. If the Company's forecasts change or excess inventory becomes obsolete, the inventory reserves included in the Company's financial statements may be understated.

Deferred Taxes - Deferred income taxes are provided for temporary differences between financial and tax reporting. Significant factors considered by the Company in estimating the probability of the realization of deferred taxes include expectations of future earnings and taxable income, as well as application of tax laws in the jurisdictions in which the Company operates.

The Company does not have off-balance sheet arrangements, financing, or other relationships with unconsolidated entities or persons, also known as "special purpose entities" (SPEs).

Impact of Inflation

Over the past five years, inflation has had a minimal effect on the Company because of low rates of inflation and the Company's policy minimizing the acceptance of long-term fixed rate contracts without provisions permitting adjustment for inflation.

Forward-Looking Statements

The foregoing discussion includes forward-looking statements relating to the business of the Company. These forward-looking statements, or other statements made by the Company, are made based on management's expectations and beliefs concerning future events impacting the Company and are subject to uncertainties and factors (including, but not limited to, those specified below) which are difficult to predict and, in many instances, are beyond the control of the Company. As a result, actual results of the Company could differ materially from those expressed in or implied by any such forward-looking statements. These uncertainties and factors include (a) the Company's dependence upon a limited number of customers and the automotive industry, (b) the highly competitive industry in which the Company operates, which includes several competitors with greater financial resources and larger sales organizations, (c) the acceptance in the marketplace of new products and/or services developed or under development by the Company including automotive diagnostic products and indicating instrument products, (d) the ability of the Company to further establish distribution and a customer base in the automotive aftermarket, (e) the Company's ability to capitalize on market opportunities including state automotive emissions programs and OEM tool programs, and (f) the Company's ability to obtain cost effective financing.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Market Risk

The Company is exposed to certain market risks from transactions that are entered into during the normal course of business. The Company has not entered into derivative financial instruments for trading purposes. The Company's primary market risks are exposure related to interest rate risk and equity market fluctuations. The Company's only debt subject to interest rate risk was various short-term demand notes with fixed interest rates. The Company has no outstanding balance on any demand notes at September 30, 2014. As a result, the Company believes that the market risk relating to interest rate movements is minimal. 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

The following pages contain the Financial Statements and Supplementary Data as specified for Item 8 of Part II of Form 10-K.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

SHAREHOLDERS AND BOARD OF DIRECTORS
HICKOK INCORPORATED
CLEVELAND, OHIO

We have audited the accompanying consolidated balance sheets of HICKOK INCORPORATED as of September 30, 2014 and 2013, and the related consolidated statements of income, stockholders' equity and cash flows for each of the years in the three-year period ended September 30, 2014. The Company's management is responsible for these consolidated financial statements. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board "United States". Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Hickok Incorporated as of September 30, 2014 and 2013, and the consolidated results of its operations and its cash flows for each of the years in the three-year period ended September 30, 2014 in conformity with accounting principles generally accepted in the United States of America.

/s/ Meaden & Moore, Ltd.

MEADEN & MOORE, Ltd.
CERTIFIED PUBLIC ACCOUNTANTS

January 6, 2015
CLEVELAND, OHIO

F-1

CONSOLIDATED BALANCE SHEET
HICKOK INCORPORATED
SEPTEMBER 30

ASSETS

				2014	2013
CURRENT ASSETS:
Cash and cash equivalents				$390,327	$938,852
Accounts receivable-less allowance for				1,172,268	638,316
	doubtful accounts of $10,000 ($10,000, 2013)
Notes receivable-current				-	-
Inventories-less allowance for obsolete				1,714,197	1,589,816
	inventory of $363,500 ($793,000, 2013)
Deferred income taxes-less valuation
	allowance of $107,700 ($334,200, 2013)			-	-
Prepaid expenses				37,989	32,342
			Total Current Assets	3,314,781	3,199,326
PROPERTY, PLANT AND EQUIPMENT:
Land				233,479	233,479
Buildings				1,429,718	1,429,718
Machinery and equipment				2,516,380	2,388,762
				4,179,577	4,051,959
Less accumulated depreciation				3,800,551	3,752,452
				379,026	299,507
OTHER ASSETS:
Deferred income taxes-less valuation
	allowance of $4,059,000 ($3,788,100, 2013)			-	-
Notes receivable-long-term				4,100	4,100
Deposits				1,750	1,750
				5,850	5,850
		Total Assets		$3,699,657	$3,504,683

See accompanying summary of accounting policies and notes to consolidated financial statements.

F-2

LIABILITIES AND STOCKHOLDERS' EQUITY

	2014	2013
CURRENT LIABILITIES:
Accounts payable	$145,557	$174,236
Accrued payroll and related expenses	132,719	142,519
Accrued expenses	178,815	395,426
Accrued taxes other than income	48,342	44,691
Total Current Liabilities	505,433	756,872
LONG-TERM LIABILITIES:
Convertible notes payable - related party	200,000	-
Accrued expenses	235,200	-
Total Long-term Liabilities	435,200	-
STOCKHOLDERS' EQUITY:
Common shares - no par value
Class A 10,000,000 shares authorized, 1,163,349 shares
issued (2014 and 2013)	1,261,188	1,261,188
Class B 2,500,000 convertible shares authorized,
475,533 shares issued	474,866	474,866
Preferred 1,000,000 shares authorized,
no shares outstanding	-	-
Contributed capital	1,741,358	1,738,521
Treasury shares - 15,795 (2014 and 2013)
Class A shares and 667 (2014 and 2013)
Class B shares	(253,341)	(253,341)
Retained earnings	(465,047)	(473,423)
Total Stockholders' Equity	2,759,024	2,747,811
Total Liabilities and Stockholders' Equity	$3,699,657	$3,504,683

F-3

CONSOLIDATED STATEMENT OF INCOME
HICKOK INCORPORATED
FOR THE YEARS ENDED SEPTEMBER 30

			2014	2013	2012
NET SALES:
Product sales			$6,078,349	$6,190,260	$4,442,133
Service sales			227,487	275,912	319,156
		Total Net Sales	6,305,836	6,466,172	4,761,289
COSTS AND EXPENSES:
Cost of product sold			3,462,092	3,359,727	2,787,212
Cost of services sold			149,068	138,307	216,949
Product development			965,975	939,373	938,058
Marketing and administrative			1,728,107	1,812,598	1,616,320
	expenses
Interest charges			6,592	91,178	5,956
Other income			(14,374)	(13,816)	(19,240)
Total Costs and Expenses			6,297,460	6,327,367	5,545,255
		Income (Loss) before Provision for Income Taxes	8,376	138,805	(783,966)
Provision For Income Taxes:
Current			(44,400)	114,400	-
Deferred			44,400	(114,400)	-
			-	-	-
		Net Income (Loss)	$8,376	$138,805	$(783,966)
		NET Income (LOSS) PER COMMON SHARE - BASIC	$.01	$.09	$(.57)
		NET Income (LOSS) PER COMMON SHARE - DILUTED	$.01	$.08	$(.57)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING			1,638,215	1,610,571	1,372,812

See accompanying summary of accounting policies and notes to consolidated financial statements.

F-4

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY
HICKOK INCORPORATED
FOR THE YEARS ENDED SEPTEMBER 30, 2014, 2013, AND 2012

		COMMON SHARES - NO PAR VALUE
	RETAINED EARNINGS	CLASS A	CLASS B	CONTRIBUTED CAPITAL	TREASURY SHARES	TOTAL
Balance at October 1, 2011	$171,738	$793,229	$454,866	$1,862,652	$(661,676)	$2,620,809
Sale of Class B shares from treasury	-	-	20,000	(391,335)	408,335	37,000
Conversion of convertible notes payable to Class A shares	-	252,368	-	214,511	-	466,879
Convertible notes issue cost	-	-	-	(34,235)	-	(34,235)
Share-based compensation expense	-	-	-	11,388	-	11,388
Net Loss	(783,966)	-	-	-	-	(783,966)
Balance at September 30, 2012	$(612,228)	$1,045,597	$474,866	$1,662,981	$(253,341)	$2,317,875
Fees for additional authorized Class A, Class B and Preferred shares	-	-	-	(21,925)	-	(21,925)
Conversion of convertible notes payable to Class A shares	-	208,591	-	-	-	208,591
Class A shares issued for professional services	-	7,000	-	-	-	7,000
Warrants issued for debt offering	-	-	-	91,000	-	91,000
Share-based compensation expense	-	-	-	6,465	-	6,465
Net Income	138,805	-	-	-	-	138,805
Balance at September 30, 2013	$(473,423)	$1,261,188	$474,866	$1,738,521	$(253,341)	$2,747,811
Share-based compensation expense	-	-	-	2,837	-	2,837
Net Income	8,376	-	-	-	-	8,376
Balance at September 30, 2014	$(465,047)	$1,261,188	$474,866	$1,741,358	$(253,341)	$2,759,024

See accompanying summary of accounting policies and notes to consolidated financial statements.

F-5

CONSOLIDATED STATEMENT OF CASH FLOWS
HICKOK INCORPORATED
FOR THE YEARS ENDED SEPTEMBER 30

	2014	2013	2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers	$5,771,884	$6,530,702	$4,781,174
Cash paid to suppliers and     employees	(6,373,180)	(5,848,654)	(5,177,377)
Interest paid	(6,174)	-	(6,641)
Interest received	659	3,874	1,057
Net Cash Provided by (Used in) Operating Activities	(606,811)	685,922	(401,787)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(141,714)	(14,443)	(55,180)
Payments received (advances) on       notes receivable	-	30,500	3,500
Proceeds on sale of assets	-	-	9,500
Net Cash Provided by (Used in) Investing Activities	(141,714)	16,057	(42,180)
CASH FLOWS FROM FINANCING ACTIVITIES:
Short-term borrowings	683,400	250,000	-
Payments on short-term borrowings	(683,400)	(250,000)	-
Payments on long-term borrowings	-	-	(250,000)
Proceeds from Convertible Notes   Payable	200,000	-	675,470
Sale of Class B shares from   treasury	-	-	37,000
Convertible notes issue costs	-	-	(34,235)
Cost for additional authorized shares	-	(21,925)	-
Net Cash Provided by (Used in) Financing Activities	200,000	(21,925)	428,235
Increase (Decrease) in Cash and Cash Equivalents	(548,525)	680,054	(15,732)
Cash and Cash Equivalents at Beginning of Year	938,852	258,798	274,530
Cash and Cash Equivalents at End of Year	$390,327	$938,852	$258,798
See accompanying summary of accounting policies and notes to consolidated financial statements.

F-6

	2014	2013	2012
RECONCILIATION OF NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Net Income (Loss)	$8,376	$138,805	$(783,966)
ADJUSTMENTS TO RECONCILE NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Depreciation	62,195	64,186	86,257
(Gain)loss on disposal of assets	-	-	(3,548)
Share-based compensation expense	2,837	6,465	11,388
Non-cash professional service expense	-	7,000	-
Warrants issued for debt offering	-	91,000	-
CHANGES IN ASSETS AND LIABILITIES:
Decrease (Increase) in accounts receivable	(533,952)	64,530	19,885
Decrease (Increase) in inventories	(124,381)	144,954	229,173
Decrease (Increase) in prepaid expenses	(5,647)	91,615	(70,690)
Increase (Decrease) in accounts payable	(28,679)	(4,599)	4,987
Increase (Decrease) in accrued payroll and   related expenses	(9,800)	(7,117)	6,687
Increase (Decrease) in other accrued   expenses and accrued taxes other than   income and long-term liabilities	22,240	89,083	98,040
Total Adjustments	(615,187)	547,117	382,179
Net Cash Provided by (Used in) Operating Activities	$(606,811)	$685,922	$(401,787)
Supplemental Schedule of Non-Cash Financing Activities:
Conversion of convertible notes payable       to Class A shares	$-	$208,591	$466,879

F-7

F-8

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
HICKOK INCORPORATED
SEPTEMBER 30, 2014, 2013 AND 2012

1. NATURE OF OPERATIONS

Hickok Incorporated and its wholly-owned domestic subsidiaries ("Company") develop and manufacture products used by companies in the transportation and emissions testing industries. Among the products are indicators and gauges sold to companies in aircraft and locomotive markets. On a much larger scale, the Company manufactures diagnostic equipment used by technicians to test the various electronic systems in automobiles and trucks, and emissions testing equipment specified by various states for testing vehicle emissions. The Company serves the automotive, locomotive and general aviation markets predominately in North America. Sales in the Company's principal product classes, as a percent of consolidated sales, are as follows:

Product Classes	2014			2013		2012
Automotive Test Equipment			76.3	%	74.4	%	66.1	%
Indicating Instruments	23.7			25.6			33.9
Total		100.0		%	100.0	%	100.0		%

Current operating properties consist of a manufacturing plant in Greenwood, Mississippi, and a corporate headquarters, marketing and product development facility in Cleveland, Ohio.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation :
The consolidated financial statements include the accounts of Hickok Incorporated and its wholly-owned domestic subsidiaries. Significant intercompany transactions and balances have been eliminated in the financial statements.

New Accounting Standards :
The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.

In May 2014, the FASB issued its final standard on the recognition of revenue from contracts with customers.  The standard, issued as Accounting Standards Update (ASU) 2014-09, outlines a single comprehensive model for entities to use in the accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry specific guidance. The core principle of this model is that “an entity recognizes revenue to depict the transfer of promised goods or services to a customer in an amount that reflects the consideration to which the entity expects to e entitled in exchange for those goods and services.” The update is effective for financial statement periods beginning after December 15, 2016, with early adoption prohibited. The Company has not determined the impact of this pronouncement on its financial statements and related disclosure.

Concentration of Credit Risk :
The Company sells its products and services primarily to customers in the United States of America and to a lesser extent overseas. All sales are made in United States of America dollars. The Company extends normal credit terms to its customers. Customers in the automotive industry comprise 87% of outstanding receivables at September 30, 2014 (60% in 2013). Sales to three customers approximated $2,768,000, $341,000 and $284,000 (2014), $2,304,000, $651,000 and $242,000 (2013), $905,000, $710,000 and $229,000 (2012), and accounts receivable to these customers amounted to approximately $731,000, $90,000 and $65,000 (2014), and $99,000, $163,000 and $14,000 (2013).

Use of Estimates in the Preparation of Financial Statements :
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that may affect the reported amounts of certain assets and liabilities and disclosure of contingencies at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments:
Accounting for "Financial Instruments" requires the Company to disclose estimated fair values of financial instruments. Financial instruments held by the Company include, among others, accounts receivable, accounts payable, and convertible notes payable. The carrying amounts reported in the consolidated balance sheet for assets and liabilities qualifying as financial instruments is a reasonable estimate of fair value.

Revenue Recognition :
The Company records sales as manufactured items are shipped to customers on an FOB shipping point arrangement, at which time title passes and the earnings process is complete. The Company primarily records service sales as the items are repaired. The customer does not have a right to return merchandise unless defective or warranty related and there are no formal customer acceptance provisions. Sales returns and allowances were immaterial during each of the three years in the period ending September 30, 2014.

Product Warranties :
The Company warrants certain products against defects for periods ranging primarily from 12 to 48 months. The Company's estimated future warranty claims is included in "Accrued expenses" and are as follows:

		2014	2013	2012
Balance October 1		$89	$451	$993
	Current year provisions	10,275	8,690	7,564
	Expenditures	(10,355)	(9,052)	(8,106)
Balance September 30		$9	$89	$451

Product Development Costs :
Product development costs, which include engineering production support, are expensed as incurred. Research and development performed for customers represents no more than 1% of sales in each year. The arrangements do not include a repayment obligation by the Company.

Cash and Cash Equivalents :
For purposes of the Statement of Cash Flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. From time to time the Company maintains cash balances in excess of the FDIC limits. The cash balance at September 30, 2014 and 2013 amounted to $390,327 and $938,852, respectively.

Accounts Receivable :
The Company establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

Inventories :
Inventories are valued at the lower of cost (first-in, first-out) or market and consist of:

	2014	2013
Raw materials and component parts	$1,066,672	$852,229
Work-in-process	521,424	590,687
Finished products	126,101	146,900
	$1,714,197	$1,589,816

Property, Plant and Equipment :
Property, plant and equipment are carried at cost. Maintenance and repair costs are expensed as incurred. Additions and betterments are capitalized. The depreciation policy of the Company is generally as follows:

Class	Method	Estimated Useful Lives
Buildings	Straight-line	10 to 40 years
Machinery and equipment	Straight-line	3 to 10 years
Tools and dies	Straight-line	3 years

Depreciation amounted to $62,195 (2014), $64,186 (2013), and $86,257 (2012).

Valuation of Long-Lived Assets :
Long-lived assets such as property, plant and equipment and software are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the total of the expected future undiscounted cash flows is less than the carrying amount of the asset, a loss is recognized for the difference between the fair value and carrying value of the asset.

Shipping and Handling Costs :
Shipping and handling costs are classified as cost of product sold.

Advertising Costs :
Advertising costs are expensed as incurred and amounted to $9,017 (2014), $6,558 (2013) and $6,940 (2012).

Income Taxes :
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus any change in deferred taxes during the year. Deferred taxes result from differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

Income per Common Share :
Income per common share information is computed on the weighted average number of shares outstanding during each period as disclosed in Note 10.

3. NOTES RECEIVABLE

Selected details of notes receivable are as follows:

	Current Portion	Total
	2014	2014	2013
Unsecured note receivable from current employee which bears interest at 3% per annum	$-	$4,100	$4,100
	$-	4,100	4,100
Less current portion		-	-
Long-term portion		$4,100	$4,100

4. CONVERTIBLE NOTES PAYABLE

On December 30, 2011, Hickok Incorporated entered into a Convertible Loan Agreement with Roundball, LLC and the Aplin Family Trust. Under the Convertible Loan Agreement, the Company issued a convertible note to Roundball in the amount of $466,879 and a convertible note to the Aplin Family Trust in the amount of $208,591. In addition, Roundball, LLC had the right to cause the Company to borrow up to an additional $466,880 from Roundball, LLC. The notes were unsecured, bore interest at a rate of 0.20% per annum and were set to mature on December 30, 2012.

The notes were convertible by the Investors at any time into Class A Common Shares of the Company, at a conversion price of $1.85 per share, although up to no more than 504,735 Conversion Shares for Roundball and no more than 112,752 Conversion Shares for the Aplin Family Trust. The Company had the option to convert the notes at the expiration date, if the investors had not during the course of the agreement. On December 30, 2011, Roundball converted $233,438 into Class A Common Shares of the Company. In addition, on August 20, 2012 Roundball converted the remaining $233,441 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 28, 2012, the Aplin Family Trust converted the $208,591 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 30, 2012, management entered into an amended Convertible Loan Agreement with Roundball which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement was by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2012 to December 30, 2013 and modified the terms to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.24%.

In partial consideration for Amendment No. 1, the Company and Roundball entered into a Warrant Agreement, dated  December 30, 2012, whereby the Company issued a warrant to Roundball to purchase, at its option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015. Roundball is an affiliate of Steven Rosen, a Director of the Company.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued was amortized over the one-year amended convertible loan agreement period. During fiscal year ended September 30, 2013, $45,500 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the fiscal year ended September 30, 2013: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

On December 30, 2013, management entered into Amendment No. 2 of the Convertible Loan Agreement with Roundball which continued to provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2013 to December 30, 2014 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.25%.

During fiscal year ended September 30, 2014, the Company borrowed $200,000 against this agreement. As of September 30, 2014, the outstanding balance on the Roundball convertible note was $200,000.

On December 31, 2014, management entered into Amendment No. 3 of the Convertible Loan Agreement with Roundball which continues to provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2014 to December 30, 2015 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.34%.

The Company recorded interest expense on the Roundball and Aplin Family Trust notes of $228 and $0 respectively for fiscal 2014, $0 and $103 respectively for fiscal 2013, and $303 and $314 respectively for fiscal 2012. As of September 30, 2014 no interest was paid.

5. SHORT-TERM FINANCING

The Company had a credit agreement of $250,000 with Robert L. Bauman, one of its major shareholders who is also an employee of the Company. The agreement was to expire in April 2013 but was modified on December 31, 2012 to extend the maturity date to December 2013. Effective October 30, 2012 for the remainder of the agreement, the lender could have terminated the agreement with 45 days written notice, and at the discretion of the Company to deny the termination notice until December 2013 if it would have had a negative effect on the solvency of the Company.

The agreement provided for a revolving credit facility of $250,000 with interest at 0.24% per annum and was unsecured and included a three-year warrant for 100,000 shares of Class A common stock at a price of $2.50 per share. In addition, the agreement generally allowed for borrowing based on an amount equal to eighty percent of eligible accounts receivables or $250,000. The revolving line of credit was not extended.

In partial consideration for the original extension of the revolving credit facility the Company and Bauman entered into a Warrant Agreement, dated December 30, 2012 whereby the Company issued a warrant to Bauman to purchase, at his option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued was amortized over the one-year credit agreement period. During fiscal year ended September 30, 2013, $45,500 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the fiscal year ended September 30, 2013: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

During the fiscal year ended September 30, 2014, the Company entered into various short-term unsecured demand notes with Robert L. Bauman borrowing a total of $683,400 with interest at 4.0%. The Company recorded interest expense of $6,364 for fiscal 2014 and $75 for fiscal 2013. As of September 30, 2014, $6,174 of interest was paid on the above notes and line of credit. The Company had no outstanding borrowings on the various short-term demand notes at September 30, 2014.

Selected details of short-term borrowings for fiscal 2014 and 2013 are as follows:

	Amount	Weighted Average Interest Rate
Balance at September 30, 2014	$-	4.00%
Average during 2014	$151,133	4.00%
Maximum during 2014 (month end)	$683,400	4.00%
Balance at September 30, 2013	$-	.24%
Average during 2013	$29,167	.24%
Maximum during 2013 (month end)	$250,000	.24%

6. LEASES

Operating :
The Company leases a facility and certain equipment under operating leases expiring through September 2016.

The Company's minimum commitment under these operating leases is as follows:

2015		$6,866
2016		2,880
2017		-
	Total	$9,746

Rental expense under these commitments was $10,521 (2014), $10,444 (2013) and $7,971 (2012).

A facility held under a capital lease has a net book value of $0 at September 30, 2014. Future minimum lease payments which extend through 2061 are immaterial.

7. STOCK OPTIONS

On February 27, 2013, the Company's 2013 Omnibus Equity Plan was approved and adopted by an affirmative vote of a majority of the Company's Class A and Class B Shareholders.

The 2013 Omnibus Plan will provide the Company with the flexibility to grant a variety of share-based awards for covered employees, consultants and Directors. The 2013 Omnibus Plan provides for the grant of the following types of incentive awards: stock options, stock appreciation rights, restricted shares, restricted share units, performance shares and Class A Common Shares. Those who will be eligible for awards under the 2013 Omnibus Plan include employees who provide services to the Company and its affiliates, executive officers, non-employee Directors and consultants designated by the Compensation Committee. The Plan has 150,000 Class A Common Shares reserved for issuance. The Class A Common Shares may be either authorized, but unissued, common shares or treasury shares. No share-based awards have been granted under the 2013 Omnibus Equity Plan as of September 30, 2014.

Under the Company's expired Key Employees Stock Option Plans there are no options currently available for grant and there are no options outstanding at September 30, 2014.

The Company's expired Outside Directors Stock Option Plans (collectively the "Directors Plans"), have provided for the automatic grant of options to purchase up to 22,000 shares of Class A Common Stock over a three-year period to members of the Board of Directors who were not employees of the Company, at the fair market value on the date of grant. The options are exercisable for up to 10 years. All options granted under the Directors Plans become fully exercisable on March 8, 2015.

Non-cash compensation expense related to stock option plans for fiscal years ended September 30, 2014, 2013 and 2012 was $2,837, $6,465 and $11,388 respectively.

Transactions involving the Directors Plans are summarized as follows:

		Weighted Average Exercise		Weighted Average Exercise		Weighted Average Exercise
	2014	Price		2013	Price	2012	Price
Option Shares
Directors Plans:
Outstanding October 1,	31,000	$5.57		42,000	$5.62	38,000	$5.95
Granted	-	-		-	-	7,000	2.925
Canceled/expired	(9,000)	6.23		(11,000)	3.55	(3,000)	3.55
Exercised	-	-		-	-	-	-
Outstanding September 30, ($2.925 to $11.00 per share)	22,000	5.30		31,000	5.57	42,000	5.62
Exercisable September 30,	20,000	5.54		25,000	6.20	30,000	6.52

The following is a summary of the range of exercise prices for stock options outstanding and exercisable under the Directors Plans at September 30, 2014.

Directors Plans	Outstanding Stock Options	Weighted Average Exercise Price	Weighted Average Remaining Life	Number of Stock Options Exercisable	Weighted Average Exercise Price
Range of exercise prices:
$2.925 - 5.25	13,000	$3.28	5.9	11,000	$3.35
$6.00 - 7.25	5,000	$6.18	3.5	5,000	$6.18
$10.50 - 11.00	4,000	$10.75	3.0	4,000	$10.75
	22,000	$5.30		20,000	$5.54

The Company accounts for Share-Based Payments under the modified prospective method for its stock options. Compensation cost for fixed based awards is measured at the grant date, and the Company uses the Black-Scholes option pricing model to determine the fair value estimates for recognizing the cost of employee and director services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. Director's stock options under the expired Outside Directors Stock Option Plans are exercisable over a three year period. The fair value of stock option grants to Directors is amortized over the three-year vesting period. During fiscal year ended September 30, 2014 and 2013, $2,837 and $6,465, respectively, was expensed as share-based compensation. Total compensation costs related to nonvested awards not yet recognized is $543 (2015). The following weighted-average assumptions were used in the option pricing model for 2014 and 2013: a risk free interest rate of 5.0% and 5.0%; an expected life of 10 and 10 years; an expected dividend yield of 0.0% and 0.0%; and a volatility factor of .87 and .87.

8. CAPITAL STOCK, TREASURY STOCK, AND CONTRIBUTED CAPITAL

On October 11, 2012, the Company's Amended Articles of Incorporation and the Amended Code of Regulations were adopted by an affirmative vote of more than two-thirds of the Company's Class A and Class B Shareholders.

The Amended Articles amend and restate the Current Articles in a number of significant ways and are primarily as follows: increased the number of Class A Shares and Class B Shares from 3,750,000 and 1,000,000 to 10,000,000 and 2,500,000 respectively, and added a class of 1,000,000 Serial Preferred Shares; eliminated par value for Class A Shares and Class B Shares; updated certain provisions relating to the payment of dividends; removed restrictions on the issuance of additional Class A Shares; clarified the method by which the Company may repurchase its shares; reduced the percentage of shareholder vote required to authorize corporate actions from two-thirds of the voting power to a majority of the voting power; and made other technical or conforming changes.

The Amended Regulations amend and restate the Current Regulations in a number of significant ways and are primarily as follows: updated certain provisions relating to the Company's meetings of shareholders in order to provide more consistency in the regulations regarding the Company's practices in this area; further clarifying the roles of the Company's officers and directors in conducting the Company's business; updated the Company's policy regarding the indemnification of its directors, officers, employees, and others; revised provisions allowing for the Board of Directors to adopt amendments to the Amended Regulations to the extent permitted by Ohio law; and made other technical or conforming changes.

Unissued shares of Class A common stock (949,233 and 958,233 shares in 2014 and 2013, respectively) are reserved for the share-for-share conversion rights of the Class B common stock, stock options under the Directors Plans, conversion rights of the Convertible Promissory Note and available warrants (see Notes 4, 5 and 7). The Class A shares have one vote per share and the Class B shares have three votes per share, except under certain circumstances such as voting on voluntary liquidation, sale of substantially all the assets, etc. Dividends up to $.10 per year, noncumulative, must be paid on Class A shares before any dividends are paid on Class B shares.

9. INCOME TAXES

A reconciliation of the provision (recovery) of income taxes to the statutory federal income tax rate is as follows:

		2014	2013	2012
Income (Loss) Before Provision for Income Taxes		$8,376	$138,805	$(783,966)
	Statutory rate	34%	34%	34%
		2,848	47,194	(266,548)
	Permanent differences	1,200	1,200	2,500
	Research and development credit - net	(46,300)	(44,900)	(8,500)
	Valuation allowance	44,400	-	274,600
	Other	(2,148)	(3,494)	(2,052)
		$-	$-	$-

Deferred tax assets (liabilities) consist of the following:

		2014	2013
Current:
	Inventories	$128,900	$277,300
	Bad debts	3,400	3,400
	Accrued liabilities	(11,700)	63,000
	Prepaid expense	(12,900)	(9,500)
		107,700	334,200
	Valuation allowance	(107,700)	(334,200)
	Total current deferred income taxes	-	-
Noncurrent:
	Depreciation and amortization	45,100	42,700
	Research and development and other credit carryforwards	1,903,800	1,830,600
	Net operating loss carryforward	1,880,200	1,817,200
	Contribution carryforward	8,900	8,900
	Directors stock option plan	40,000	39,000
	Acquisition costs	101,000	49,700
	Accrued liabilities	80,000	-
		4,059,000	3,788,100
	Valuation allowance	(4,059,000)	(3,788,100)
	Total long-term deferred income taxes	-	-
	Total	$-	$-

The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

The Company is subject to U.S federal jurisdiction income tax examinations for the tax years 2010 through 2012. In addition, the Company is subject to state and local income tax examinations for the tax years 2010 through 2012.

The Company has available a net operating loss carryforward of approximately $5,500,000, and a research and development credit carryforward of approximately $1,800,000, and a contribution carryforward of approximately $26,000. The net operating loss, research and development credit and contribution carryforwards will begin to expire in fiscal 2025, 2016, and 2015 respectively.

Management has recorded a valuation allowance on the entire balance of deferred tax assets due to the losses during the past several years, the current economic uncertainties, the negative effects of the recent economic crisis on all the Company's markets and concern that a more likely than not expiration of the Company's net operating loss, research and development credit and contribution carryforwards could occur before they can be used.

The Company's ability to realize the entire benefit of its deferred tax assets requires that the Company achieve certain future earning levels prior to the expiration of its net operating loss, research and development credit and contribution carryforwards. Because of the uncertainties involved with this significant estimate, it is reasonably possible that the Company's estimate may change in the near term.

10. EARNINGS PER COMMON SHARE

The following table sets forth the computation of basic and diluted earnings per share.

	2014	2013	2012
Basic Income (Loss) Per Share
Income (Loss) available to common stockholders	$8,376	$138,805	$(783,966)
Shares denominator	1,638,215	1,610,571	1,372,812
Per share amount	$.01	$.09	$(.57)
Effect of Dilutive Securities
Average shares outstanding	1,638,215	1,610,571	1,372,812
Options available under convertible note	31,097	23,505	-
	1,669,312	1,634,076	1,372,812
Diluted Income (Loss) Per Share
Income (Loss) available to common stockholders	$8,376	$138,805	$(783,966)
Per share amount	$.01	$.08	$(.57)

Options and warrants to purchase 22,000 and 200,000 shares of common stock respectively during fiscal 2014 at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In fiscal 2013 options and warrants to purchase 31,000 and 200,000 shares of common stock respectively at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In fiscal 2012 options to purchase 42,000 shares of common stock at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common share. In addition, conversion rights to purchase 365,119 shares of common stock at a price of $1.85 per share were not included in the computation of diluted earnings per share because the conversion rights of the Convertible Promissory Notes effect was antidilutive.

11. EMPLOYEE BENEFIT PLANS

The Company has a 401(k) Savings and Retirement Plan covering all full-time employees. Company contributions to the plan, including matching of employee contributions, are at the Company's discretion. For fiscal years ended September 30, 2014, 2013 and 2012, the Company made matching contributions to the plan in the amount of $16,979, $16,003 and $15,178, respectively. The Company does not provide any other postretirement benefits to its employees.

12. SEGMENT AND RELATED INFORMATION

The Company's four business units have a common management team and infrastructure. The indicators and gauges unit has different technologies and customers than the other business units. Therefore, the business units have been aggregated into two reportable segments: 1.) indicators and gauges and 2.) automotive related diagnostic tools and equipment. The Company's management evaluates segment performance based primarily on operating earnings before taxes. Non-operating items such as interest income and interest expense are included in general corporate expenses. Depreciation expense on assets used in manufacturing are considered part of each segment's operating performance. Depreciation expense on non-manufacturing assets is included in general corporate expenses.

Indicators and Gauges:
This segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to both original equipment manufacturers and to operators of railroad equipment.

Automotive Diagnostic Tools and Equipment:
This segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEMs and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions.

Information by industry segment is set forth below:

Years Ended September 30,		2014			2013			2012
Net Sales
	Indicators and Gauges		$1,492,348			$1,657,725				$1,612,943
	Automotive Diagnostic Tools and Equipment	4,813,488			4,808,447			3,148,346
			$6,305,836			$6,466,172			$4,761,289
Income (Loss) Before Provision for Income Taxes
	Indicators and Gauges		$312,692			$433,361					$271,343
	Automotive Diagnostic Tools and Equipment	704,427			834,630			(78,433)
	General Corporate Expenses	(1,008,743)			(1,129,186)			(976,876)
				$8,376			$138,805		$(783,966)

Asset Information :

Years Ended September 30,		2014		2013
Identifiable Assets
	Indicators and Gauges		$685,198		$898,555
	Automotive Diagnostic Tools and Equipment	2,199,779		1,327,932
	Corporate	814,680		1,278,196
			$3,699,657		$3,504,683

Geographical Information :
Included in the consolidated financial statements are the following amounts related to geographic locations:

Years Ended September 30,		2014	2013	2012
Revenue:
	United States of America	$6,149,883	$6,317,722	$4,598,029
	Australia	64,744	23,481	14,018
	Canada	58,983	77,239	72,535
	Mexico	25,288	16,640	36,960
	Taiwan	-	22,481	34,935
	Other foreign countries	6,938	8,609	4,812
		$6,305,836	$6,466,172	$4,761,289

All export sales to Australia, Canada, Mexico, Taiwan and other foreign countries are made in United States of America Dollars.

13. COMMITMENTS AND CONTINGENCIES

Legal Matters:
The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the Company's results of operations, financial position or cash flows.

14. SUBSEQUENT EVENTS

The Company has analyzed its operations subsequent to September 30, 2014 through the date the financial statements were submitted to the Securities and Exchange Commission, and has determined that no subsequent events have occurred that would require recognition in the consolidated financial statements or disclosure in the notes to the consolidated financial statements, except as follows:

On December 31, 2014, management entered into an amended Convertible Loan Agreement which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2014 to December 30, 2015 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.34% per annum.

In addition, the Company's legal firm handling the patent infringement case discussed in Note 13 to the Company's financial statements has provided a letter indicating the firm will not seek to be paid by the Company prior to February 1, 2016, unbilled legal fees in excess of $45,000 unless the Lawsuit is settled prior to February 1, 2016.

Lastly, in December 2014, the Company issued a non-binding proposal letter to acquire the membership interests of Federal Hose LLC, a wholly owned subsidiary of First Francis Company, Inc. First Francis is owned by certain directors of the Company and the terms of the potential transaction are still being negotiated.

15. BUSINESS CONDITION AND MANAGEMENT PLAN

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has suffered recurring losses from operations during the past several years due primarily to decreasing sales of existing product lines and a general economic downturn in all markets the Company serves. The resulting lower sales levels have impacted the Company's accounts receivable and cash balances, if this situation continues it may prevent the Company from generating sufficient cash flow to sustain its operations.

The ability of the Company to continue as a going concern is dependent on improving the Company's profitability and cash flow and securing additional financing if needed. Management continues to review and revise its strategic plan and believes in the viability of its strategy to increase revenues and profitability through increased sales of existing products and the introduction of new products to the market place. Management believes that the actions presently being taken by the Company will provide the stimulus for it to continue as a going concern, however, because of the inherent uncertainties there can be no assurances to that effect. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Additionally, the Company has net operating loss carryforwards, currently valued at $0, that offset taxable income.

In addition, on December 31, 2014, management entered into an amended unsecured convertible loan agreement which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The unsecured convertible loan agreement is with a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement and continues to allow $250,000 of borrowing on the agreement at the Company's discretion. This facility is available through December 2015. The Company has borrowed $200,000 on the loan agreement during the year and it is outstanding at September 30, 2014.

Management’s strategic plan to increase revenues and profitability through increased sales of existing products, the introduction of new products to the market place and the cash generated from the completion of the large order from a Tier 1 Supplier during the current fiscal year should provide the Company with the needed working capital for the next twelve months. 
 
16. QUARTERLY DATA (UNAUDITED)

	First	Second	Third	Fourth
Net Sales
2014	$1,050,242	$1,116,467	$2,130,412	$2,008,715
2013	1,738,903	1,964,338	1,339,931	1,423,000
2012	1,181,501	1,178,538	1,271,803	1,129,447
Gross Profit
2014	360,838	428,031	1,124,914	780,893
2013	812,501	856,177	572,192	727,268
2012	392,712	402,681	479,189	482,546
Net Income (Loss)
2014	(320,287)	(297,655)	386,911	239,407
2013	143,804	119,431	(133,777)	9,347
2012	(183,140)	(224,781)	(170,975)		(205,070)
Net Income (Loss) per Common Share
Basic
2014	(.20)	(.18)	.24	.15
2013	.09	.08	(.08)	.01
2012	(.15)	(.16)	(.12)	(.14)
Diluted
2014	(.20)	(.18)	.23	.14
2013	.09	.07	(.08)	.01
2012	(.15)	(.16)	(.12)	(.14)

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

Not Applicable.

ITEM 9A. CONTROLS AND PROCEDURES.

As of September 30, 2014, an evaluation was performed, under the supervision and with the participation of the Company's management, including the Company's Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based upon that evaluation, the Company's management, including the Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, concluded that the Company's disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended ("Exchange Act") were effective as of September 30, 2014 to ensure that information required to be disclosed by the Company in reports that it files and submits under the Exchange Act is (1) recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms, and (2) is accumulated and communicated to the Company's management, including its principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. There were no changes in the Company's internal controls over financial reporting during the fourth fiscal quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect the Company's internal control over financial reporting.

The Company's internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles. The Company's internal control over financial reporting includes policies and procedures that (1) pertain to maintaining records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company assets, (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that the Company's receipts and expenditures are being made only in accordance with authorization of the Company's management and directors, and (3) provide reasonable assurance regarding prevention or the timely detection of unauthorized acquisition, use or disposal of the company's assets that could have a material effect on the financial statements.

Management, including the Company's Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, does not expect that the Company's internal controls will prevent or detect all errors and all fraud. An internal control system no matter how well designed and operated can provide only reasonable, not absolute, assurance that the objectives of the system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, collusion of two or more people, or by management override of the control. Also, any evaluation of the effectiveness of controls in future periods are subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

The management of Hickok Incorporated is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in rules 13a-15(f) and 15d-15(f) of the Securities Exchange Act of 1934, as amended. Under the supervision and with the participation of management, including the Company's Chief Executive Officer along with the Company's Vice President, Finance and Chief Financial Officer, we conducted an evaluation of the effectiveness of the Company's internal control over financial reporting as of September 30, 2014, as required by Rule 13a-15(c) of the Securities Exchange Act of 1934, as amended. In making this assessment, we used the criteria set forth in the framework in Internal Control-Integrated Framework (1992) for Small Public Companies issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control-Integrated Framework for Small Public Companies, our management concluded that our internal control over financial reporting was effective as of September 30, 2014.

This annual report does not include an attestation report of the Company's registered public accounting firm regarding internal control over financial reporting. Management's report was not subject to attestation by the Company's registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management's report in this annual report.

/s/ R. L. Bauman

R. L. Bauman
Chief Executive Officer

/s/ G. M. Zoloty

G. M. Zoloty
Chief Financial Officer

January 13, 2015

ITEM 9B. OTHER INFORMATION.

Not Applicable.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

The information required by this Item 10 as to the Directors of the Company is incorporated herein by reference to the information set forth under the caption "Information Concerning Nominees for Directors" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015, since such Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the end of the Company's fiscal year pursuant to Regulation 14A. Information required by this Item 10 as to the Executive Officers of the Company is included in Part I of this Annual Report on Form 10-K. Information required by this Item as to the Audit Committee, the Audit Committee financial expert, the procedures for recommending nominees to the Board of Directors and compliance with Section 16(a) of the Exchange Act is incorporated herein by reference to the information set forth under the captions "Information Regarding Meetings and Committees of the Board of Directors" and "Section 16(a) Beneficial Ownership Reporting Compliance" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015.

The Company has historically operated under informal ethical guidelines, under which the Company's principal executive, financial, and accounting officers, are held accountable. In accordance with these guidelines, the Company has always promoted honest, ethical and lawful conduct throughout the organization and has adopted a written Code of Ethics for the Chief Executive Officer and Chief Financial Officer. In addition, the Company adopted and the Board of Directors approved a written Code of Business Conduct for all officers and employees. The Company also implemented a system to address the "Whistle Blower" provision of the Sarbanes-Oxley Act of 2002.

ITEM 11. EXECUTIVE COMPENSATION.

The information required by this Item 11 is incorporated by reference to the information set forth under the caption "Executive Compensation" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015, since such Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the end of the Company's fiscal year pursuant to Regulation 14A.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

Equity Compensation Plan Information

The following table provides information as of September 30, 2014 with respect to compensation plans (including individual compensation arrangements) under which Common Stock of the Company is authorized for issuance under compensation plans previously approved and not previously approved by shareholders of the Company.

(a) (b) (c)

Plan category Number of securities to be issued upon exercise of outstanding options, warrants and rights Weighted-average exercise price of outstanding options, warrants and rights Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (1)

________________________________________________________________________________

Equity compensation plans approved by security holders 20,000 $5.54 150,000

Equity compensation plans not approved by security holders	-	-	-
Total	20,000		150,000

(1)Represents the total amount of securities available under the Hickok Incorporated 2013 Omnibus Equity Plan (the "Plan"). Types of awards issuable under the Plan include stock options, stock appreciation rights, restricted shares, restricted share units, preference shares and Class A Common Shares in such amounts determined by the Compensation Committee. No securities have been issued under the Plan.

Other information required by this Item 12 is incorporated by reference to the information set forth under the captions "Principal Shareholders" and "Share Ownership of Directors and Officers" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015, since such Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the end of the Company's fiscal year pursuant to Regulation 14A.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

The information required by this Item 13 is incorporated by reference to the information set forth under the caption "Transactions with Management" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015, since such Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the end of the Company's fiscal year pursuant to Regulation 14A.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

The information required by this Item 14 is incorporated by reference to the information set forth under the caption "Independent Public Accountants" in the Company's definitive Proxy Statement for the Annual Meeting of Shareholders to be held on February 25, 2015, since such Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the end of the Company's fiscal year pursuant to Regulation 14A.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

(a) (1) FINANCIAL STATEMENTS

The following Consolidated Financial Statements of the Registrant and its subsidiaries are included in Part II, Item 8:

PAGE

Report of Independent Registered Public Accounting Firm	F-1
Consolidated Balance Sheet - As of September 30, 2014 and 2013	F-2
Consolidated Statement of Income - Years Ended September 30, 2014, 2013 and 2012	F-4
Consolidated Statement of Stockholders' Equity - Years Ended September 30, 2014, 2013 and 2012	F-5
Consolidated Statement of Cash Flows - Years Ended September 30, 2014, 2013 and 2012	F-6
Notes to Consolidated Financial Statements	F-8

(a) (2) FINANCIAL STATEMENT SCHEDULES

The following Consolidated Financial Statement Schedules of the Registrant and its subsidiaries are included in Item 15 hereof.

SEQUENTIAL PAGE

Report of Independent Registered Public Accounting Firm as to Schedules

Schedule II - Valuation and Qualifying Accounts

All other Schedules for which provision is made in the applicable accounting regulation of the Securities and Exchange Commission are not required under the related instructions or are inapplicable, and therefore have been omitted.

(a) (3) EXHIBITS Reference is made to the Exhibit Index set forth herein.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HICKOK INCORPORATED

By: /s/ Robert L. Bauman
Robert L. Bauman
President and Chief Executive Officer
Date: January 13, 2015

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on the 13th day of January, 2015:

SIGNATURE:	TITLE
/s/ Brian E. Powers	Chairman
Brian E. Powers
/s/ Robert L. Bauman	President and Chief Executive Officer
Robert L. Bauman	(Principal Executive Officer)
/s/ Gregory M. Zoloty	Vice President and Chief Financial
Gregory M. Zoloty	Officer
	(Principal Financial and Accounting Officer)
/s/ Edward F. Crawford	Director
Edward F. Crawford
/s/ Matthew V. Crawford	Director
Matthew V. Crawford
/s/ Jennifer A. Elliott	Director
Jennifer A. Elliott
/s/ James T. Martin	Director
James T. Martin
/s/ Steven H. Rosen	Director
Steven H. Rosen
/s/ Janet H. Slade	Director
Janet H. Slade
/s/ Kirin M. Smith	Director
Kirin M. Smith

EXHIBIT INDEX

EXHIBIT NO.: DOCUMENT

3(a)	Amended Articles of Incorporation. (incorporated herein by reference to the appropriate exhibit to the Company's Form 10-K as filed with the Commission on January 14, 2013).
3(b)	Amended and Restated Code of Regulations. (incorporated herein by reference to the appropriate exhibit to the Company's Form 10-K as filed with the Commission on January 14, 2013).
10(a)	Convertible Promissory Note, dated April 9, 2014, issued by the Company to Roundball in the principal amount of $100,000.00 (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 2, 2014) effective through December 30, 2014.
10(b)	Convertible Promissory Note, dated May 2, 2014, issued by the Company to Roundball in the principal amount of $100,000.00 (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 2, 2014) effective through December 30, 2014.
10(c)	Hickok Incorporated 2003 Outside Directors Stock Option Plan (incorporated herein by reference to the appropriate exhibit to the Company's Registration Statement on Form S-8 as filed with the Commission on June 9, 2005).**
10(d)	Hickok Incorporated 2007 Outside Directors Stock Option Plan (incorporated herein by reference to Appendix A of the  Company's definitive proxy statement for its 2007 annual meeting of shareholders as filed with the Commission on January 22, 2007).**
10(e)	Hickok Incorporated 2010 Outside Directors Stock Option Plan (incorporated herein by reference to Appendix A of the Company's definitive proxy statement for its 2010 annual meeting of shareholders as filed with the Commission on January 26, 2010).**
10(f)	Hickok Incorporated 2013 Omnibus Equity Plan (incorporated herein by reference to Appendix A of the Company's definitive proxy statement for its 2013 annual meeting of shareholders as filed with the Commission on January 28, 2013).**
10(g)	Convertible Loan Agreement, dated December 30, 2011, among the Company, the Investors, and solely with respect to Section 3 thereof, Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(h)	Convertible Promissory Note, dated December 30, 2011, issued by the Company to Roundball in the principal amount of $466,879.87 (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(i)	Convertible Promissory Note, dated December 30, 2011, issued by the Company to the Aplin Trust in the principal amount of $208,591.20 (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(j)	Registration Rights Agreement, dated December 30, 2011, among the Company and the Investors (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(k)	Voting Agreement, dated December 30, 2011, among the Company, the Investors and the Class B Shareholders of the Company (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(l)	Subscription Agreement, dated December 30, 2011, between the Company and Roundball (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012) effective through December 30, 2012.
10(m)	Form of Employment Agreement (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 5, 2012).**
10(n)	Warrant Agreement, dated December 30, 2012, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 4, 2013) effective through December 30, 2015.
10(o)	Amendment No. 1 to Convertible Loan Agreement, dated December 30, 2012, by and between the Company and Roundball, LLC. (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 4, 2013) effective through December 30, 2013.
10(p)	Warrant Agreement, dated December 30, 2012, by and between the Company and Roundball, LLC. (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 4, 2013) effective through December 30, 2015.
10(q)	Amendment No. 2 to Convertible Loan Agreement, dated December 30, 2013, by and between the Company and Roundball, LLC. (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 1, 2014) effective through December 30, 2014.
10(r)	Credit Promissory Note No. 1, dated April 24, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 15, 2014).
10(s)	Credit Promissory Note No. 2, dated May 2, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 15, 2014).
10(t)	Credit Promissory Note No. 3, dated May 6, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 15, 2014).
10(u)	Credit Promissory Note No. 4, dated May 8, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 15, 2014).
10(v)	Credit Promissory Note No. 5, dated May 21, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 30, 2014).
10(w)	Credit Promissory Note No. 6, dated May 29, 2014, by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on May 30, 2014).
10(x)	Credit Promissory Note No. 7, dated June 20, 2014 by and between the Company and Robert L. Bauman (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on June 23, 2014).
10(y)	Amendment No. 3 to Convertible Loan Agreement, dated December 31, 2014, by and between the Company and Roundball, LLC. (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 6, 2015) effective through December 30, 2015.
10(z)	Amendment No. 1 to Registration Rights Agreement, dated December 31, 2014, by and between the Company and Roundball, LLC. (incorporated herein by reference to the appropriate exhibit to the Company's Form 8-K as filed with the Commission on January 6, 2015) effective through December 30, 2015.
11	Computation of Net Income Per Common Share.
14	Hickok Incorporated Financial Code of Ethics for the Chief Executive Officer and Specified Financial Officers.
21	Subsidiaries of the Registrant.
23	Consent of Independent Registered Public Accounting Firm.
31.1	Rule 13a-14(a)/15d-14(a)Certification by the Chief Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a)Certification by the Chief Financial Officer.
32.1	Certification by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*	XBRL Instance
101.SCH*	XBRL Taxonomy Extension Schema
101.CAL*	XBRL Taxonomy Extension Calculation
101.DEF*	XBRL Extension Definition
101.LAB*	XBRL Taxonomy Extension Labels
101.PRE*	XBRL Taxonomy Extension Presentation

*XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

**Management contract, compensation plan or arrangement.

The following pages contain the Consolidated Financial Statement Schedules as specified for Item 8 of Part II of Form 10-K.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AS TO CONSOLIDATED SCHEDULES

To the Shareholders and Board of Directors
Hickok Incorporated
Cleveland, Ohio

We have audited the consolidated financial statements of HICKOK INCORPORATED (the "Company") as of September 30, 2014 and 2013, and for each of the years in the three-year period ended September 30, 2014, and have issued our report thereon dated January 6, 2015; such consolidated financial statements and report are included in Part II, Item 8 of this Form 10-K. Our audits also included the consolidated financial statement schedules ("schedules") of the Company listed in Part IV, Item 15. These schedules are the responsibility of the Company's management. Our responsibility is to express an opinion based on our audits. In our opinion, such schedules, when considered in relation to the basic financial statements taken as a whole, present fairly in all material respects the information set forth therein.

/s/ Meaden & Moore, Ltd.

MEADEN & MOORE, Ltd.
Certified Public Accountants

January 6, 2015
Cleveland, Ohio

                                               HICKOK INCORPORATED

                                  SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

     
      Col. A                         Col. B                   Col. C                  Col. D          Col. E
-----------------------             ----------   -------------------------------    ---------     ------------

                                           
                                                           Additions
                                                 -------------------------------

                                 
                                    Balance at     Charged to        Charged to                        Balance
                                    Beginning      Costs and           Other                           at End
    Description                     of Period      Expenses          Accounts        Deductions       of Period
-----------------------------       ----------    ------------     ------------      -----------     ------------
Deducted from Asset Accounts:
                                
                                                    
                                                  Year Ended September 30, 2012
                                                  ------------------------------

 Reserve for doubtful accounts       $   10,000    $      374 (1)    $      - (2)     $     374 (3)     $   10,000

 Reserve for inventory obsolescence  $  714,000    $  185,697        $      -         $  48,697 (4)     $  851,000

 Reserve for product warranty        $      993    $    7,565        $      -         $   8,107         $      451

 Valuation allowance deferred taxes  $4,049,300    $  187,400        $      -         $       -         $4,236,700

                                                  
                                                  Year Ended September 30, 2013
                                                  ------------------------------

 Reserve for doubtful accounts       $   10,000    $    2,049 (1)    $      - (2)     $   2,049 (3)     $   10,000

 Reserve for inventory obsolescence  $  851,000    $   60,107        $      -         $ 118,107 (4)     $  793,000
 
 Reserve for product warranty        $      451    $    8,690        $      -         $   9,052         $       89
 
 Valuation allowance deferred taxes  $4,236,700    $        -        $      -         $ 114,400         $4,122,300


                                                Year Ended September 30, 2014
                                                  ------------------------------

 Reserve for doubtful accounts       $   10,000    $  (4,446) (1)    $      - (2)     $ (4,446) (3)     $   10,000

 Reserve for inventory obsolescence  $  793,000    $(113,603)        $      -         $ 315,897 (4)     $  363,500

 Reserve for product warranty        $       89    $   10,275        $      -         $  10,335         $        9
 
 Valuation allowance deferred taxes  $4,122,300    $   44,400        $      -         $       -         $4,166,700



(1) Classified as bad debt expense. 

(2) Recoveries on accounts charged off in prior years.

(3) Accounts charged off during year as uncollectible.

(4) Inventory charged off during the year as obsolete. 

EX-10

Exhibit 10(a)

CONVERTIBLE
PROMISSORY NOTE

$100.000 Cleveland, Ohio
April 9, 2014

FOR VALUE RECEIVED, Hickok Incorporated, an Ohio corporation ("Borrower"), hereby promises to pay to the order of Roundball LLC, an Ohio limited liability company, its successors and assigns (herein referred to as "Holder"), with an address of 25101 Chagrin Boulevard, Suite 350, Beachwood, Ohio 44122, or at such other place as the Holder may from time to time designate, the principal sum of One Hundred Thousand Dollars ($100,000) (the "Loan"), with interest thereon at the time and in the manner set forth herein.  

1.     Loan Agreement. This Convertible Promissory Note ("Note") has been executed and delivered by the Borrower pursuant to the terms of that certain Convertible Loan Agreement, dated of as of December 30, 2011, as amended by Amendment No. 2 thereto dated December 30, 2013 (the “Loan Agreement”).  All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Loan Agreement.

2.    Principal and Interest.

(a)    The unpaid principal balance of this Note shall bear interest at a rate equal to 0.25% per annum, computed monthly.

(b)    If full payment of the principal and interest is not made when due, the amount of the unpaid interest shall be added to the principal balance of this Note.

(c)    Interest shall be payable on the Maturity Date (as defined below).  Interest shall be computed on the basis of the actual number of days elapsed over a 360-day year.

(d)    If all or any portion of the principal balance or any of the accrued interest under this Note shall not be paid for any reason by the Maturity Date or on such earlier date that payment becomes due pursuant to the Loan Agreement or this Note, then all accrued and unpaid interest at such date shall be added to and become part of the unpaid principal balance at the Maturity Date or the date of acceleration, whichever is earlier.

3.     Term.  The entire principal balance of this Note, together with all accrued interest thereon, shall be due and payable on December 30, 2014, unless (a) accelerated as set forth in Section 7, (b) the Holder, in its sole and absolute discretion, exercises its Lender Conversion Option, in whole, pursuant to Section 2.2.2 of the Loan Agreement prior to December 30, 2014, or (c) Borrower exercises its Borrower Conversion Option pursuant to Section 2.2.5 of the Loan Agreement (the "Maturity Date").

4.     Prepayment.  The Borrower may prepay the Note, in whole or in part, at any time upon notice as provided for in the Loan Agreement, subject to Holder's conversion rights upon prepayment set forth in Section 2.2.1 therein.

5     Application of Payments.  All payments made hereunder shall be applied first to the reasonable expenses, if any, including reasonable attorney's fees, of the Holder incurred in the collection of this Note following default, then to accrued interest, which shall be due and payable upon any prepayment, and then to principal.

6.     Conversion.  This Note is subject to, and entitled to the benefits of, the Lender Conversion Option and the Borrower Conversion Option set forth in Section 2.2 of the Loan Agreement.  Nothing in this Note is intended to limit such conversion privileges and to the extent there is any inconsistency between the terms of this Note and such conversion privileges, the terms of the Loan Agreement shall govern. Borrower acknowledges that, if Holder converts a portion, but less than all, of this Note pursuant to the exercise of its Lender Conversion Option, Borrower shall cancel this Note and execute and deliver to Lender a replacement Note in the aggregate principal amount of the unconverted portion of the Note surrendered.

7.     Events of Default.  If any of the "Events of Default" as that term is defined in Section 11 of the Loan Agreement, shall occur and shall not be cured within the time limits set forth in said Section 11, then, the principal amount of this Note, together with all accrued and unpaid interest thereon and all other amounts payable under this Note may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Loan Agreement.

8.     Payment of Costs and Expenses. The Borrower agrees to pay all losses, costs and expenses, including reasonable attorneys fees, in connection with the enforcement of the Note, the Loan Agreement and any other instruments and documents delivered in connection herewith sustained as a result of the occurrence of an Event of Default by the Borrower.

9.     Amendments. The terms of this Note are subject to amendment only in the manner provided for in the Loan Agreement.

10.     Invalidity of any Provisions in Note.  If, for any reason, any of the terms or provisions (or any part of any provision) hereof are found to be invalid, illegal, unenforceable or contrary to any applicable law, such invalidity, illegality or unenforceability shall not affect any other provision (or any remaining part of any provision) of this Note, but this Note shall be construed as if such invalid, illegal or unenforceable provision (or any part thereof) had never been contained herein, and the Borrower hereby agrees that this Note shall still remain in full force and effect subject only to the exclusion of those terms or provisions (and only to the extent to which such terms or provisions) shall have been found invalid, illegal, unenforceable or contrary to any such applicable law.

11.     Presentment, Demand and Notice Waived.  The Borrower waives presentment for payment, demand and notice of demand, notice of non-payment, protest and notice of protest, notice of dishonor and trial by jury in any litigation arising out of, relating to, or connected with this Note, the Loan Agreement or any other Loan Document.

12.     Governing Law.  This Note shall be governed and construed in accordance with the laws of the State of Ohio (but not including the choice of law rules thereof).

IN WITNESS WHEREOF, the Borrower has caused this Note to be executed by its duly authorized officer as of the date first above written.

HICKOK INCORPORATED
 
By: /s/ Robert L. Bauman
     Robert L. Bauman

Its: President and CEO

EX-10

Exhibit 10(b)

CONVERTIBLE
PROMISSORY NOTE

$100.000 Cleveland, Ohio
May 2, 2014

FOR VALUE RECEIVED, Hickok Incorporated, an Ohio corporation ("Borrower"), hereby promises to pay to the order of Roundball LLC, an Ohio limited liability company, its successors and assigns (herein referred to as "Holder"), with an address of 25101 Chagrin Boulevard, Suite 350, Beachwood, Ohio 44122, or at such other place as the Holder may from time to time designate, the principal sum of One Hundred Thousand Dollars ($100,000) (the "Loan"), with interest thereon at the time and in the manner set forth herein.  

1.     Loan Agreement. This Convertible Promissory Note ("Note") has been executed and delivered by the Borrower pursuant to the terms of that certain Convertible Loan Agreement, dated of as of December 30, 2011, as amended by Amendment No. 2 thereto dated December 30, 2013 (the “Loan Agreement”).  All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Loan Agreement.

2.    Principal and Interest.

(a)    The unpaid principal balance of this Note shall bear interest at a rate equal to 0.25% per annum, computed monthly.

(b)    If full payment of the principal and interest is not made when due, the amount of the unpaid interest shall be added to the principal balance of this Note.

(c)    Interest shall be payable on the Maturity Date (as defined below).  Interest shall be computed on the basis of the actual number of days elapsed over a 360-day year.

(d)    If all or any portion of the principal balance or any of the accrued interest under this Note shall not be paid for any reason by the Maturity Date or on such earlier date that payment becomes due pursuant to the Loan Agreement or this Note, then all accrued and unpaid interest at such date shall be added to and become part of the unpaid principal balance at the Maturity Date or the date of acceleration, whichever is earlier.

3.     Term.  The entire principal balance of this Note, together with all accrued interest thereon, shall be due and payable on December 30, 2014, unless (a) accelerated as set forth in Section 7, (b) the Holder, in its sole and absolute discretion, exercises its Lender Conversion Option, in whole, pursuant to Section 2.2.2 of the Loan Agreement prior to December 30, 2014, or (c) Borrower exercises its Borrower Conversion Option pursuant to Section 2.2.5 of the Loan Agreement (the "Maturity Date").

4.     Prepayment.  The Borrower may prepay the Note, in whole or in part, at any time upon notice as provided for in the Loan Agreement, subject to Holder's conversion rights upon prepayment set forth in Section 2.2.1 therein.

5     Application of Payments.  All payments made hereunder shall be applied first to the reasonable expenses, if any, including reasonable attorney's fees, of the Holder incurred in the collection of this Note following default, then to accrued interest, which shall be due and payable upon any prepayment, and then to principal.

6.     Conversion.  This Note is subject to, and entitled to the benefits of, the Lender Conversion Option and the Borrower Conversion Option set forth in Section 2.2 of the Loan Agreement.  Nothing in this Note is intended to limit such conversion privileges and to the extent there is any inconsistency between the terms of this Note and such conversion privileges, the terms of the Loan Agreement shall govern. Borrower acknowledges that, if Holder converts a portion, but less than all, of this Note pursuant to the exercise of its Lender Conversion Option, Borrower shall cancel this Note and execute and deliver to Lender a replacement Note in the aggregate principal amount of the unconverted portion of the Note surrendered.

7.     Events of Default.  If any of the "Events of Default" as that term is defined in Section 11 of the Loan Agreement, shall occur and shall not be cured within the time limits set forth in said Section 11, then, the principal amount of this Note, together with all accrued and unpaid interest thereon and all other amounts payable under this Note may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Loan Agreement.

8.     Payment of Costs and Expenses. The Borrower agrees to pay all losses, costs and expenses, including reasonable attorneys fees, in connection with the enforcement of the Note, the Loan Agreement and any other instruments and documents delivered in connection herewith sustained as a result of the occurrence of an Event of Default by the Borrower.

9.     Amendments. The terms of this Note are subject to amendment only in the manner provided for in the Loan Agreement.

10.     Invalidity of any Provisions in Note.  If, for any reason, any of the terms or provisions (or any part of any provision) hereof are found to be invalid, illegal, unenforceable or contrary to any applicable law, such invalidity, illegality or unenforceability shall not affect any other provision (or any remaining part of any provision) of this Note, but this Note shall be construed as if such invalid, illegal or unenforceable provision (or any part thereof) had never been contained herein, and the Borrower hereby agrees that this Note shall still remain in full force and effect subject only to the exclusion of those terms or provisions (and only to the extent to which such terms or provisions) shall have been found invalid, illegal, unenforceable or contrary to any such applicable law.

11.     Presentment, Demand and Notice Waived.  The Borrower waives presentment for payment, demand and notice of demand, notice of non-payment, protest and notice of protest, notice of dishonor and trial by jury in any litigation arising out of, relating to, or connected with this Note, the Loan Agreement or any other Loan Document.

12.     Governing Law.  This Note shall be governed and construed in accordance with the laws of the State of Ohio (but not including the choice of law rules thereof).

IN WITNESS WHEREOF, the Borrower has caused this Note to be executed by its duly authorized officer as of the date first above written.

HICKOK INCORPORATED
 
By: /s/ Robert L. Bauman
      Robert L. Bauman

Its: President and CEO

EX-11

Exhibit 11

HICKOK INCORPORATED
CONSOLIDATED STATEMENT OF COMPUTATION OF EARNINGS
PER COMMON SHARE AND SHARE EQUIVALENTS

Years Ended September 30,	2014	2013	2012
NET INCOME
Net income (loss) applicable to common shares for basic earnings per share	$8,376	$138,805	$(783,966)
Net Income (loss) applicable to common shares for diluted earnings per share	$8,376	$138,805	$(783,966)
SHARES OUTSTANDING
Weighted average shares for basic earnings per share	1,638,215	1,610,571	1,372,812
Net effect of dilutive options available under convertible note - based on the treasury stock method using year-end market price, if higher than average market price	31,097	23,505	-*
Total shares for diluted earnings per share	1,669,312	1,634,076	1,372,812
Basic Earnings Per Common Share	$.01	$.09	$(.57)
Diluted Earnings Per Common Share	$.01	$.08	$(.57)
* Net effect of stock options was antidilutive for the period.

EX-14

Exhibit 14

HICKOK INCORPORATED

FINANCIAL CODE OF ETHICS
FOR THE
CHIEF EXECUTIVE OFFICER AND
SPECIFIED FINANCIAL OFFICERS

This Hickok Incorporated Financial Code of Ethics applies to Hickok’s principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. Hickok expects all of its employees to act with personal and professional integrity in all aspects of their employment, to comply with all applicable laws, rules and regulations, to deter wrongdoing and to abide by Hickok’s other policies and procedures that govern the conduct of Hickok employees. This Financial Code of Ethics is intended to supplement Hickok’s other policies and procedures.

You shall:

(1)    Engage in and promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;

(2)    Produce full, fair, accurate, timely, and understandable disclosure in reports and documents that Hickok files with, or submits to, the Securities and Exchange Commission and other regulators and in other public communications made by Hickok;

(3)    Comply with applicable governmental laws, rules and regulations, as well as the rules and regulations of self-regulatory organizations of which Hickok is a member;
 
(4)    Promptly report any possible violation of this Financial Code of Ethics to the Chairman of the Audit Committee; and

(5)    Take all reasonable measures to protect the confidentiality of non-public, proprietary information about Hickok and its customers obtained or created in connection with your activities and to prevent the unauthorized disclosure of such information unless required by applicable law or regulation or legal or regulatory process.

You understand that you are prohibited from directly or indirectly taking any action to fraudulently influence, coerce, manipulate or mislead Hickok’s independent public accountants for the purpose of rendering the financial statements of Hickok misleading.

You further understand that you will be held accountable for your adherence to this Financial Code of Ethics. Your failure to observe the terms of this Financial Code of Ethics may result in disciplinary action. Violations of this Financial Code of Ethics also may constitute violations of law and may result in civil and criminal penalties for you and/or Hickok.

EX-21

Exhibit 21

                            HICKOK INCORPORATED


Subsidiaries of Registrant


COMPANY NAME                              STATE OF INCORPORATION

Supreme Electronics LLC                 Mississippi

Waekon LLC                              Ohio

EX-23

Exhibit 23

                         CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8
(Nos. 33-68196, 333-63597 and 333-125672) of Hickok Incorporated (the "Company") of our report dated
January 6, 2015, related to the consolidated balance sheets as of September 30, 2014 and 2013,
and the related consolidated statements of income, stockholders' equity, and cash flows for each of
the years in the three-year period ended September 30, 2014, which appear in this Form 10-K. 



/s/ Meaden & Moore, Ltd.

MEADEN & MOORE, Ltd.    
Independent Registered Public Accounting Firm
Cleveland, Ohio
January 6, 2015

EX-31

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION 

 
I, Robert L. Bauman, certify that:

1. I have reviewed this annual report on Form 10-K of Hickok Incorporated (the "registrant");
    

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
   c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
   d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
   
   

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:

/s/ R. L. Bauman

R. L. Bauman

Chief Executive Officer

January 13, 2015

EX-31

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

 

I, Gregory M. Zoloty, certify that:

1. I have reviewed this annual report on Form 10-K of Hickok Incorporated (the "registrant");
    

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
    

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
    

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

   a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
   
   b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
   
   c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
   
   d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
   
   

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

By:

 /s/ G. M. Zoloty

G. M. Zoloty

Vice President, Finance and Chief Financial Officer

January 13, 2015

EX-32

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Hickok Incorporated (the "Company") on Form 10-K for the period ending September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert L. Bauman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ R. L. Bauman

R. L. Bauman

Chief Executive Officer

January 13, 2015

EX-32

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Hickok Incorporated (the "Company") on Form 10-K for the period ending September 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Gregory M. Zoloty, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ G. M. Zoloty

G. M. Zoloty

Chief Financial Officer

January 13, 2015

XML

Note 2 - Summary of Significant Accounting Policies (Details) - Property, Plant and Equipment Useful Lives	12 Months Ended
	Sep. 30, 2014
Building [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years
Building [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	40 years
Building [Member]
Property, Plant and Equipment [Line Items]
Method	Straight-line
Machinery and Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Useful life	3 years
Machinery and Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Useful life	10 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Method	Straight-line
Tools, Dies and Molds [Member]
Property, Plant and Equipment [Line Items]
Method	Straight-line
Useful life	3 years

XML

Note 9 - Income Taxes (Details) - Deferred Tax Assets (Liabilities) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Current:
Inventories	$ 128,900	$ 277,300
Accrued liabilities	(11,700)	63,000
Prepaid expense	(12,900)	(9,500)
	107,700	334,200
Valuation allowance	(107,700)	(334,200)
Noncurrent:
Depreciation and amortization	45,100	42,700
Research and development and other credit carryforwards	1,903,800	1,830,600
Net operating loss carryforward	1,880,200	1,817,200
Contribution carryforward	8,900	8,900
Directors stock option plan	40,000	39,000
Acquisition costs	101,000	49,700
Accrued liabilities	80,000
	4,059,000	3,788,100
Valuation allowance	(4,059,000)	(3,788,100)
Bad Debts [Member]
Current:
Bad debts	$ 3,400	$ 3,400

XML

Note 7 - Stock Options (Details) - Transactions Involving the Directors Plans (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Option Shares Directors Plans:
Granted	0
Directors Plans [Member]
Option Shares Directors Plans:
Outstanding October 1,	31,000	42,000	38,000
Outstanding October 1,	$ 5.57	$ 5.62	$ 5.95
Granted			7,000
Granted			$ 2.925
Canceled/expired	(9,000)	(11,000)	(3,000)
Canceled/expired	$ 6.23	$ 3.55	$ 3.55
Outstanding September 30, ($2.925 to $11.00 per share)	22,000	31,000	42,000
Outstanding September 30, ($2.925 to $11.00 per share)	$ 5.30	$ 5.57	$ 5.62
Exercisable September 30,	20,000	25,000	30,000
Exercisable September 30,	$ 5.54	$ 6.20	$ 6.52

XML

Note 10 - Earnings Per Common Share (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Equity Option [Member] | Minimum [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Share Price			2.925
Equity Option [Member] | Maximum [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Share Price			11.00
Equity Option [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	22,000	31,000	42,000
Warrant [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	200,000	200,000
Options And Warrants [Member] | Minimum [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Share Price	2.50	2.50
Options And Warrants [Member] | Maximum [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Share Price	11.00	11.00
Conversion Rights [Member]
Note 10 - Earnings Per Common Share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			365,119
Share Price			1.85

XML

Note 6 - Leases (Details) - The Company's Minimum Commitment Under Operating leases (USD $)	Sep. 30, 2014
The Company's Minimum Commitment Under Operating leases [Abstract]
2015	$ 6,866
2016	2,880
Total	$ 9,746

XML

Note 12 - Segment and Related Information (Tables)

12 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Years Ended September 30,	2014			2013			2012
Net Sales
Indicators and Gauges	$	1,492,348		$	1,657,725		$	1,612,943
Automotive Diagnostic Tools and Equipment		4,813,488			4,808,447			3,148,346
	$	6,305,836		$	6,466,172		$	4,761,289
Income (Loss) Before Provision for Income Taxes
Indicators and Gauges	$	312,692		$	433,361		$	271,343
Automotive Diagnostic Tools and Equipment		704,427			834,630			(78,433	)
General Corporate Expenses		(1,008,743	)		(1,129,186	)		(976,876	)
	$	8,376		$	138,805		$	(783,966	)

Years Ended September 30,	2014		2013		2012
Revenue:
United States of America	$	6,149,883	$	6,317,722	$	4,598,029
Australia		64,744		23,481		14,018
Canada		58,983		77,239		72,535
Mexico		25,288		16,640		36,960
Taiwan		-		22,481		34,935
Other foreign countries		6,938		8,609		4,812
	$	6,305,836	$	6,466,172	$	4,761,289

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

Years Ended September 30,	2014		2013
Identifiable Assets
Indicators and Gauges	$	685,198	$	898,555
Automotive Diagnostic Tools and Equipment		2,199,779		1,327,932
Corporate		814,680		1,278,196
	$	3,699,657	$	3,504,683

XML

Note 11 - Employee Benefit Plans (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 16,979	$ 16,003	$ 15,178

XML

Note 1 - Nature of Operations (Tables)

12 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Product Classes	2014			2012			2012
Automotive Test Equipment		76.3	%		74.4	%	66.1	%
Indicating Instruments		23.7			25.6		33.9
Total		100.0	%		100.0	%	100.0	%

XML

Note 7 - Stock Options (Details) - Summary of Range of Exercise Prices for Stock Options Outstanding and Exercisable Directors Plans (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Lower exercise price	$ 2.925	$ 2.925	$ 2.925
Upper exercise price	$ 11.00	$ 11.00	$ 11.00
Price Range 1 [Member] | Directors Plans [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Lower exercise price	$ 2.925
Upper exercise price	$ 5.25
Outstanding stock options (in Shares)	13,000
Weighted average exercise price, outstanding	$ 3.28
Weighted average remaining life, outstanding	5 years 328 days
Exercisable stock options (in Shares)	11,000
Weighted average exercise price, exercisable	$ 3.35
Price Range 2 [Member] | Directors Plans [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Lower exercise price	$ 6.00
Upper exercise price	$ 7.25
Outstanding stock options (in Shares)	5,000
Weighted average exercise price, outstanding	$ 6.18
Weighted average remaining life, outstanding	3 years 6 months
Exercisable stock options (in Shares)	5,000
Weighted average exercise price, exercisable	$ 6.18
Price Range 3 [Member] | Directors Plans [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Lower exercise price	$ 10.50
Upper exercise price	$ 11.00
Outstanding stock options (in Shares)	4,000
Weighted average exercise price, outstanding	$ 10.75
Weighted average remaining life, outstanding	3 years
Exercisable stock options (in Shares)	4,000
Weighted average exercise price, exercisable	$ 10.75
Directors Plans [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding stock options (in Shares)	22,000
Weighted average exercise price, outstanding	$ 5.30
Exercisable stock options (in Shares)	20,000
Weighted average exercise price, exercisable	$ 5.54

XML

Note 4 - Convertible Notes Payable (Details) (USD $)	12 Months Ended			1 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Aug. 20, 2012	Dec. 30, 2011	Dec. 28, 2012	Dec. 30, 2012	Dec. 31, 2013	Dec. 31, 2014	Dec. 30, 2013
Note 4 - Convertible Notes Payable (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 2.50
Interest Expense, Debt		$ 45,500
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate		0.42%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Term		3 years
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate		0.00%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate		0.84%
Proceeds from Convertible Debt	200,000		675,470
Common Class A [Member] | Roundball LLC [Member] | Convertible Notes Payable [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Debt Instrument, Convertible, Conversion Price (in Dollars per share)					$ 1.85
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)					504,735
Conversion of Stock, Amount Converted				233,441	233,438
Common Class A [Member] | Roundball LLC [Member] | Amendment No. 1 [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)							100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)							$ 2.50
Common Class A [Member] | Aplin Family Trust [Member] | Convertible Notes Payable [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)					112,752
Common Class A [Member] | Convertible Notes Payable [Member] | Aplin Family Trust [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Conversion of Stock, Amount Converted						208,591
Common Class A [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	100,000						100,000
Roundball LLC [Member] | Convertible Notes Payable [Member] | Additional Borrowing [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Proceeds from Issuance of Debt					466,880
Roundball LLC [Member] | Convertible Notes Payable [Member] | Director [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								0.24%
Working Capital Funding							467,000
Line of Credit Facility, Maximum Borrowing Capacity								250,000
Roundball LLC [Member] | Convertible Notes Payable [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Convertible Notes Payable, Current					466,879
Debt Instrument, Interest Rate, Stated Percentage							0.20%
Roundball LLC [Member] | Subsequent Event [Member] | Amendment No 3 [Member] | Director [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage									0.34%
Working Capital Funding									467,000
Line of Credit Facility, Maximum Borrowing Capacity									250,000
Roundball LLC [Member] | Amendment No 2 [Member] | Director [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Debt Instrument, Interest Rate, Stated Percentage										0.25%
Working Capital Funding										467,000
Line of Credit Facility, Maximum Borrowing Capacity										250,000
Roundball LLC [Member] | Amendment No 2 [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Convertible Notes Payable, Current	200,000
Proceeds from Convertible Debt	200,000
Roundball LLC [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Interest Expense, Debt	228	0	303
Aplin Family Trust [Member] | Convertible Notes Payable [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Convertible Notes Payable, Current					208,591
Aplin Family Trust [Member]
Note 4 - Convertible Notes Payable (Details) [Line Items]
Interest Expense, Debt	$ 0	$ 103	$ 314

XML

Note 2 - Summary of Significant Accounting Policies (Details) - Estimated Future Warranty Claims (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Estimated Future Warranty Claims [Abstract]
Balance October 1	$ 89	$ 451	$ 993
Balance September 30	9	89	451
Current year provisions	10,275	8,690	7,564
Expenditures	$ (10,355)	$ (9,052)	$ (8,106)

XML

Note 9 - Income Taxes (Details) (USD $)	Sep. 30, 2014
Note 9 - Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	$ 5,500,000
Contribution Carryforward	26,000
Research Tax Credit Carryforward [Member]
Note 9 - Income Taxes (Details) [Line Items]
Tax Credit Carryforward, Amount	$ 1,800,000

XML

Note 14 - Subsequent Events (Details) (USD $)	Dec. 31, 2014	Sep. 30, 2014
Majority Shareholder [Member] | Subsequent Event [Member]
Note 14 - Subsequent Events (Details) [Line Items]
Convertible Debt	$ 467,000
Majority Shareholder [Member]
Note 14 - Subsequent Events (Details) [Line Items]
Due to Related Parties		250,000
Debt Instrument, Interest Rate, Stated Percentage		0.34%
Subsequent Event [Member]
Note 14 - Subsequent Events (Details) [Line Items]
Convertible Debt	467,000
Accrued Professional Fees	$ 45,000

XML

Note 7 - Stock Options (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Dec. 30, 2012	Sep. 30, 2011
Note 7 - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	0
Allocated Share-based Compensation Expense	$ 2,837	$ 6,465	$ 11,388
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate		0.84%
Common Class A [Member] | 2013 Omnibus Equity Plan [Member]
Note 7 - Stock Options (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	150,000
Common Class A [Member]
Note 7 - Stock Options (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	949,233	958,233
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	100,000			100,000
Expired Plan [Member]
Note 7 - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	0
Expired Directors Plans [Member]
Note 7 - Stock Options (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	22,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	10 years
Directors Plans [Member]
Note 7 - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			7,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	22,000	31,000	42,000		38,000
Allocated Share-based Compensation Expense	2,837	6,465
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Remaining Contractual Term	3 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized	$ 543
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	5.00%	5.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	10 years	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%	0.00%
Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate	0.87%	0.87%

XML

Note 3 - Notes Receivable

12 Months Ended

Sep. 30, 2014

Receivables [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

3. NOTES RECEIVABLE 

Selected details of notes receivable are as follows: 

	Current Portion		Total
	2014		2014		2013
Unsecured note receivable from current employee which bears interest at 3% per annum	$	-	$	4,100	$	4,100
	$	-		4,100		4,100
Less current portion				-		-
Long-term portion			$	4,100	$	4,100

XML

Note 15 - Business Condition and Management Plan (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2014
Note 15 - Business Condition and Management Plan (Details) [Line Items]
Operating Loss Carryforward Net of Allowance	$ 0
Line of Credit Facility, Current Borrowing Capacity	250,000
Proceeds from Related Party Debt	200,000
Subsequent Event [Member]
Note 15 - Business Condition and Management Plan (Details) [Line Items]
Convertible Debt		$ 467,000

XML

Note 5 - Short-term Financing (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Dec. 30, 2012	Dec. 31, 2013
Note 5 - Short-term Financing (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$ 2.50
Line of Credit Facility, Current Borrowing Capacity	$ 250,000
Class of Warrant or Right Amortized Period	1 year
Interest Expense, Debt		45,500
Interest Paid	6,174		6,641
Common Class A [Member]
Note 5 - Short-term Financing (Details) [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)	100,000			100,000
Robert L. Bauman [Member]
Note 5 - Short-term Financing (Details) [Line Items]
Due to Related Parties, Current					250,000
Line of Credit Facility, Maximum Amount Outstanding During Period	250,000
Line of Credit Facility, Interest Rate During Period	0.24%
Warrant Period	3 years
Interest Expense, Debt	6,364	75
Proceeds from Short-term Debt	683,400
Debt Instrument, Interest Rate, Stated Percentage	4.00%
Interest Paid	6,174
Short-term Debt	0
Warrant Agreement [Member]
Note 5 - Short-term Financing (Details) [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)				2.50
Interest Expense, Debt		$ 45,500
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate		0.42%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term		3 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate		0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate		0.84%

XML

Note 6 - Leases (Tables)

12 Months Ended

Sep. 30, 2014

Leases [Abstract]

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

2015	$	6,866
2016		2,880
2017		-
Total	$	9,746

XML

Note 5 - Short-term Financing (Tables)

12 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Schedule of Short-term Debt [Table Text Block]

	Amount		Weighted Average Interest Rate
Balance at September 30, 2014	$	-		4.00	%
Average during 2014	$	151,133		4.00	%
Maximum during 2014 (month end)	$	683,400		4.00	%
Balance at September 30, 2013	$	-		.24	%
Average during 2013	$	29,167		.24	%
Maximum during 2013 (month end)	$	250,000		.24	%

XML

Note 10 - Earnings Per Common Share (Details) - Summary of Earnings Per Share Calculation (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Basic Income (Loss) Per Share
Income (Loss) available to common stockholders (in Dollars)	$ 8,376	$ 138,805	$ (783,966)
Shares denominator	1,638,215	1,610,571	1,372,812
Per share amount (in Dollars per share)	$ 0.01	$ 0.09	$ (0.57)
Effect of Dilutive Securities
Average shares outstanding	1,638,215	1,610,571	1,372,812
Options available under convertible note	31,097	23,505
	1,669,312	1,634,076	1,372,812
Diluted Income (Loss) Per Share
Income (Loss) available to common stockholders (in Dollars)	$ 8,376	$ 138,805	$ (783,966)
Per share amount (in Dollars per share)	$ 0.01	$ 0.08	$ (0.57)

XML

Note 5 - Short-term Financing (Details) - Summary of Short-term and Long-term Borrowings (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Summary of Short-term and Long-term Borrowings [Abstract]
Weighted average interest rate	4.00%	0.24%
Average amount (in Dollars)	$ 151,133	$ 29,167
Average interest rate	4.00%	0.24%
Maximum amount (in Dollars)	$ 683,400	$ 250,000
Interest rate at month end	4.00%	0.24%

XML

Note 7 - Stock Options (Tables)

12 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

				Weighted Average Exercise					Weighted Average Exercise					Weighted Average Exercise
	2014			Price		2013			Price		2012			Price
Option Shares Directors Plans:
Outstanding October 1,		31,000		$	5.57		42,000		$	5.62		38,000		$	5.95
Granted		-			-		-			-		7,000			2.925
Canceled/expired		(9,000	)		6.23		(11,000	)		3.55		(3,000	)		3.55
Exercised		-			-		-			-		-			-
Outstanding September 30, ($2.925 to $11.00 per share)		22,000			5.30		31,000			5.57		42,000			5.62
Exercisable September 30,		20,000			5.54		25,000			6.20		30,000			6.52

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

Directors Plans			Outstanding Stock Options		Weighted Average Exercise Price		Weighted Average Remaining Life		Number of Stock Options Exercisable		Weighted Average Exercise Price
Range of exercise prices:
$2.925	-	5.25		13,000	$	3.28		5.9		11,000	$	3.35
$6.00	-	7.25		5,000	$	6.18		3.5		5,000	$	6.18
$10.50	-	11.00		4,000	$	10.75		3.0		4,000	$	10.75
				22,000	$	5.30				20,000	$	5.54

XML

Note 9 - Income Taxes (Tables)

12 Months Ended

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

	2014			2013			2012
Income (Loss) Before Provision for Income Taxes	$	8,376		$	138,805		$	(783,966	)
Statutory rate		34	%		34	%		34	%
		2,848			47,194			(266,548	)
Permanent differences		1,200			1,200			2,500
Research and development credit - net		(46,300	)		(44,900	)		(8,500	)
Valuation allowance		44,400			-			274,600
Other		(2,148	)		(3,494	)		(2,052	)
	$	-		$	-		$	-

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

	2014			2013
Current:
Inventories	$	128,900		$	277,300
Bad debts		3,400			3,400
Accrued liabilities		(11,700	)		63,000
Prepaid expense		(12,900	)		(9,500	)
		107,700			334,200
Valuation allowance		(107,700	)		(334,200	)
Total current deferred income taxes		-			-
Noncurrent:
Depreciation and amortization		45,100			42,700
Research and development and other credit carryforwards		1,903,800			1,830,600
Net operating loss carryforward		1,880,200			1,817,200
Contribution carryforward		8,900			8,900
Directors stock option plan		40,000			39,000
Acquisition costs		101,000			49,700
Accrued liabilities		80,000			-
		4,059,000			3,788,100
Valuation allowance		(4,059,000	)		(3,788,100	)
Total long-term deferred income taxes		-			-
Total	$	-		$	-

XML

Note 2 - Summary of Significant Accounting Policies

12 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation :
The consolidated financial statements include the accounts of Hickok Incorporated and its wholly-owned domestic subsidiaries. Significant intercompany transactions and balances have been eliminated in the financial statements.

New Accounting Standards :
The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.
In May 2014, the FASB issued its final standard on the recognition of revenue from contracts with customers.  The standard, issued as Accounting Standards Update (ASU) 2014-09, outlines a single comprehensive model for entities to use in the accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry specific guidance. The core principle of this model is that “an entity recognizes revenue to depict the transfer of promised goods or services to a customer in an amount that reflects the consideration to which the entity expects to e entitled in exchange for those goods and services.” The update is effective for financial statement periods beginning after December 15, 2016, with early adoption prohibited. The Company has not determined the impact of this pronouncement on its financial statements and related disclosure.

Concentration of Credit Risk :
The Company sells its products and services primarily to customers in the United States of America and to a lesser extent overseas. All sales are made in United States of America dollars. The Company extends normal credit terms to its customers. Customers in the automotive industry comprise 87% of outstanding receivables at September 30, 2014 (60% in 2013). Sales to three customers approximated $2,768,000, $341,000 and $284,000 (2014), $2,304,000, $651,000 and $242,000 (2013), $905,000, $710,000 and $229,000 (2012), and accounts receivable to these customers amounted to approximately $731,000, $90,000 and $65,000 (2014), and $99,000, $163,000 and $14,000 (2013).

Use of Estimates in the Preparation of Financial Statements :
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that may affect the reported amounts of certain assets and liabilities and disclosure of contingencies at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments:
Accounting for "Financial Instruments" requires the Company to disclose estimated fair values of financial instruments. Financial instruments held by the Company include, among others, accounts receivable, accounts payable, and convertible notes payable. The carrying amounts reported in the consolidated balance sheet for assets and liabilities qualifying as financial instruments is a reasonable estimate of fair value.

Revenue Recognition :
The Company records sales as manufactured items are shipped to customers on an FOB shipping point arrangement, at which time title passes and the earnings process is complete. The Company primarily records service sales as the items are repaired. The customer does not have a right to return merchandise unless defective or warranty related and there are no formal customer acceptance provisions. Sales returns and allowances were immaterial during each of the three years in the period ending September 30, 2014.

Product Warranties :
The Company warrants certain products against defects for periods ranging primarily from 12 to 48 months. The Company's estimated future warranty claims is included in "Accrued expenses" and are as follows:

	2014			2013			2012
Balance October 1	$	89		$	451		$	993
Current year provisions		10,275			8,690			7,564
Expenditures		(10,355	)		(9,052	)		(8,106	)
Balance September 30	$	9		$	89		$	451

Product Development Costs :
Product development costs, which include engineering production support, are expensed as incurred. Research and development performed for customers represents no more than 1% of sales in each year. The arrangements do not include a repayment obligation by the Company.

Cash and Cash Equivalents :
For purposes of the Statement of Cash Flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. From time to time the Company maintains cash balances in excess of the FDIC limits. The cash balance at September 30, 2014 and 2013 amounted to $390,327 and $938,852, respectively.

Accounts Receivable :
The Company establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

Inventories :
Inventories are valued at the lower of cost (first-in, first-out) or market and consist of:

	2014		2013
Raw materials and component parts	$	1,066,672	$	852,229
Work-in-process		521,424		590,687
Finished products		126,101		146,900
	$	1,714,197	$	1,589,816

Property, Plant and Equipment :
Property, plant and equipment are carried at cost. Maintenance and repair costs are expensed as incurred. Additions and betterments are capitalized. The depreciation policy of the Company is generally as follows:

Class	Method	Estimated Useful Lives
Buildings	Straight-line	10	-	40	years
Machinery and equipment	Straight-line	3	-	10	years
Tools and dies	Straight-line		3		years

Depreciation amounted to $62,195 (2014), $64,186 (2013), and $86,257 (2012).

Valuation of Long-Lived Assets :
Long-lived assets such as property, plant and equipment and software are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the total of the expected future undiscounted cash flows is less than the carrying amount of the asset, a loss is recognized for the difference between the fair value and carrying value of the asset.

Shipping and Handling Costs :
Shipping and handling costs are classified as cost of product sold.

Advertising Costs :
Advertising costs are expensed as incurred and amounted to $9,017 (2014), $6,558 (2013) and $6,940 (2012).

Income Taxes :
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus any change in deferred taxes during the year. Deferred taxes result from differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

Income per Common Share :
Income per common share information is computed on the weighted average number of shares outstanding during each period as disclosed in Note 10.

XML

Note 10 - Earnings Per Common Share (Tables)

12 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

	2014		2013		2012
Basic Income (Loss) Per Share
Income (Loss) available to common stockholders	$	8,376	$	138,805	$	(783,966	)
Shares denominator		1,638,215		1,610,571		1,372,812
Per share amount	$	.01	$	.09	$	(.57	)
Effect of Dilutive Securities
Average shares outstanding		1,638,215		1,610,571		1,372,812
Options available under convertible note		31,097		23,505		-
		1,669,312		1,634,076		1,372,812
Diluted Income (Loss) Per Share
Income (Loss) available to common stockholders	$	8,376	$	138,805	$	(783,966	)
Per share amount	$	.01	$	.08	$	(.57	)

XML

Note 3 - Notes Receivable (Details) - Summary of Notes Receivable (USD $)	Sep. 30, 2014	Sep. 30, 2013
Related Party Transaction [Line Items]
Unsecured note receivable from current employee	$ 4,100	$ 4,100
Long-term portion	4,100	4,100
Current Employee [Member]
Related Party Transaction [Line Items]
Unsecured note receivable from current employee	$ 4,100	$ 4,100

XML

Note 9 - Income Taxes (Details) - Income Tax Reconciliation (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Income Tax Reconciliation [Abstract]
Income (Loss) Before Provision for Income Taxes	$ 8,376	$ 138,805	$ (783,966)
Statutory rate	34.00%	34.00%	34.00%
	2,848	47,194	(266,548)
Permanent differences	1,200	1,200	2,500
Research and development credit - net	(46,300)	(44,900)	(8,500)
Valuation allowance	44,400		274,600
Other	$ (2,148)	$ (3,494)	$ (2,052)

XML

Consolidated Balance Sheet (USD $)	Sep. 30, 2014	Sep. 30, 2013
CURRENT ASSETS:
Cash and cash equivalents	$ 390,327	$ 938,852
Accounts receivable-less allowance for doubtful accounts of $10,000 ($10,000, 2013)	1,172,268	638,316
Notes receivable-current	0	0
Inventories-less allowance for obsolete inventory of $363,500 ($793,000, 2013)	1,714,197	1,589,816
Deferred income taxes-less valuation allowance of $107,700 ($334,200, 2013)	0	0
Prepaid expenses	37,989	32,342
Total Current Assets	3,314,781	3,199,326
PROPERTY, PLANT AND EQUIPMENT:
Land	233,479	233,479
Buildings	1,429,718	1,429,718
Machinery and equipment	2,516,380	2,388,762
	4,179,577	4,051,959
Less accumulated depreciation	3,800,551	3,752,452
	379,026	299,507
OTHER ASSETS:
Deferred income taxes-less valuation allowance of $4,059,000 ($3,788,100, 2013)	0	0
Notes receivable-long-term	4,100	4,100
Deposits	1,750	1,750
	5,850	5,850
Total Assets	3,699,657	3,504,683
CURRENT LIABILITIES:
Accounts payable	145,557	174,236
Accrued payroll and related expenses	132,719	142,519
Accrued expenses	178,815	395,426
Accrued taxes other than income	48,342	44,691
Total Current Liabilities	505,433	756,872
LONG-TERM LIABILITIES:
Convertible notes payable - related party	200,000
Accrued expenses	235,200
Total Long-term Liabilities	435,200
STOCKHOLDERS' EQUITY:
Preferred 1,000,000 shares authorized, no shares outstanding
Contributed capital	1,741,358	1,738,521
Treasury shares - 15,795 (2014 and 2013) Class A shares and 667 (2014 and 2013) Class B shares	(253,341)	(253,341)
Retained earnings	(465,047)	(473,423)
Total Stockholders' Equity	2,759,024	2,747,811
Total Liabilities and Stockholders' Equity	3,699,657	3,504,683
Common Class A [Member]
STOCKHOLDERS' EQUITY:
Class of common stock - value	1,261,188	1,261,188
Common Class B [Member]
STOCKHOLDERS' EQUITY:
Class of common stock - value	$ 474,866	$ 474,866

XML

Note 6 - Leases (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Leases [Abstract]
Operating Leases, Rent Expense	$ 10,521	$ 10,444	$ 7,971
Capital Leased Assets Net Book Value	$ 0

XML

Consolidated Statement of Cash Flows (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Cash received from customers	$ 5,771,884	$ 6,530,702	$ 4,781,174
Cash paid to suppliers and employees	(6,373,180)	(5,848,654)	(5,177,377)
Interest paid	(6,174)		(6,641)
Interest received	659	3,874	1,057
Net Cash Provided by (Used in) Operating Activities	(606,811)	685,922	(401,787)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(141,714)	(14,443)	(55,180)
Payments received (advances) on notes receivable		30,500	3,500
Proceeds on sale of assets			9,500
Net Cash Provided by (Used in) Investing Activities	(141,714)	16,057	(42,180)
CASH FLOWS FROM FINANCING ACTIVITIES:
Short-term borrowings	683,400	250,000
Payments on short-term borrowings	(683,400)	(250,000)
Payments on long-term borrowings			(250,000)
Proceeds from Convertible Notes Payable	200,000		675,470
Sale of Class B shares from treasury			37,000
Convertible notes issue costs			(34,235)
Cost for additional authorized shares		(21,925)
Net Cash Provided by (Used in) Financing Activities	200,000	(21,925)	428,235
Increase (Decrease) in Cash and Cash Equivalents	(548,525)	680,054	(15,732)
Cash and Cash Equivalents at Beginning of Year	938,852	258,798	274,530
Cash and Cash Equivalents at End of Year	390,327	938,852	258,798
RECONCILIATION OF NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Net Income (Loss)	8,376	138,805	(783,966)
ADJUSTMENTS TO RECONCILE NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Depreciation	62,195	64,186	86,257
(Gain)loss on disposal of assets			(3,548)
Share-based compensation expense	2,837	6,465	11,388
Warrants issued for debt offering		91,000
CHANGES IN ASSETS AND LIABILITIES:
Decrease (Increase) in accounts receivable	(533,952)	64,530	19,885
Decrease (Increase) in inventories	(124,381)	144,954	229,173
Decrease (Increase) in prepaid expenses	(5,647)	91,615	(70,690)
Increase (Decrease) in accounts payable	(28,679)	(4,599)	4,987
Increase (Decrease) in accrued payroll and related expenses	(9,800)	(7,117)	6,687
Increase (Decrease) in other accrued expenses and accrued taxes other than income and long-term liabilities	22,240	89,083	98,040
Total Adjustments	(615,187)	547,117	382,179
Net Cash Provided by (Used in) Operating Activities	(606,811)	685,922	(401,787)
Supplemental Schedule of Non-Cash Financing Activities:
Conversion of convertible notes payable to Class A shares		208,591	466,879
Professional Service Expense [Member]
ADJUSTMENTS TO RECONCILE NET INCOME (LOSS) TO NET CASH PROVIDED BY OPERATING ACTIVITIES:
Non-cash professional service expense		$ 7,000

XML

Note 12 - Segment and Related Information (Details) - Information by Industry Segment (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Net Sales
Net sales	$ 6,305,836	$ 6,466,172	$ 4,761,289
Income (Loss) Before Provision for Income Taxes
Income (loss) before provistion for income taxes	8,376	138,805	(783,966)
Indicators and Gauges [Member]
Net Sales
Net sales	1,492,348	1,657,725	1,612,943
Income (Loss) Before Provision for Income Taxes
Income (loss) before provistion for income taxes	312,692	433,361	271,343
Automotive Diagnostic Tools and Equipment [Member]
Net Sales
Net sales	4,813,488	4,808,447	3,148,346
Income (Loss) Before Provision for Income Taxes
Income (loss) before provistion for income taxes	704,427	834,630	(78,433)
Corporate, Non-Segment [Member]
Income (Loss) Before Provision for Income Taxes
Income (loss) before provistion for income taxes	(1,008,743)	(1,129,186)	(976,876)
UNITED STATES
Net Sales
Net sales	6,149,883	6,317,722	4,598,029
AUSTRALIA
Net Sales
Net sales	64,744	23,481	14,018
CANADA
Net Sales
Net sales	58,983	77,239	72,535
MEXICO
Net Sales
Net sales	25,288	16,640	36,960
TAIWAN, PROVINCE OF CHINA
Net Sales
Net sales		22,481	34,935
Other Foreign Countries [Member]
Net Sales
Net sales	$ 6,938	$ 8,609	$ 4,812

XML

Note 1 - Nature of Operations (Details) - Summary of Company's Product Classes	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Segment Reporting Information [Line Items]
Product classes	100.00%	100.00%	100.00%
Automotive Test Equipment [Member]
Segment Reporting Information [Line Items]
Product classes	76.30%	74.40%	66.10%
Indicating Instruments [Member]
Segment Reporting Information [Line Items]
Product classes	23.70%	25.60%	33.90%

XML

Note 16 - Quarterly Data (Unaudited)

12 Months Ended

Sep. 30, 2014

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

16. QUARTERLY DATA (UNAUDITED)

	First			Second			Third			Fourth
Net Sales
2014	$	1,050,242		$	1,116,467		$	2,130,412		$	2,008,715
2013		1,738,903			1,964,338			1,339,931			1,423,000
2012		1,181,501			1,178,538			1,271,803			1,129,447
Gross Profit
2014		360,838			428,031			1,124,914			780,893
2013		812,501			856,177			572,192			727,268
2012		392,712			402,681			479,189			482,546
Net Income (Loss)
2014		(320,287	)		(297,655	)		386,911			239,407
2013		143,804			119,431			(133,777	)		9,347
2012		(183,140	)		(224,781	)		(170,975	)		(205,070	)
Net Income (Loss) per Common Share
Basic
2014		(.20	)		(.18	)		.24			.15
2013		.09			.08			(.08	)		.01
2012		(.15	)		(.16	)		(.12	)		(.14	)
Diluted
2014		(.20	)		(.18	)		.23			.14
2013		.09			.07			(.08	)		.01
2012		(.15	)		(.16	)		(.12	)		(.14	)

XML

Note 2 - Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2011
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net	$ 6,305,836	$ 6,466,172	$ 4,761,289
Percentage of Research and Development to Sales	1.00%
Cash and Cash Equivalents, at Carrying Value	390,327	938,852	258,798	274,530
Depreciation	62,195	64,186	86,257
Advertising Expense	9,017	6,558	6,940
Customer 1 [Member] | Accounts Receivable [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net			905,000
Accounts Receivable, Net	731,000	99,000
Customer 1 [Member] | Sales Revenue, Goods, Net [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net	2,768,000	2,304,000
Customer 2 [Member] | Accounts Receivable [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net			710,000
Accounts Receivable, Net	90,000	163,000
Customer 2 [Member] | Sales Revenue, Goods, Net [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net	341,000	651,000
Customer 3 [Member] | Accounts Receivable [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Accounts Receivable, Net	65,000	14,000
Customer 3 [Member] | Sales Revenue, Goods, Net [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net	284,000	242,000
Customer 3 [Member] | Customer 3 [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Revenue, Net			$ 229,000
Accounts Receivable [Member] | Automotive Industry [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage	87.00%	60.00%
Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Number of Customers	3
Minimum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Warranty Period	12 months
Maximum [Member]
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
Warranty Period	48 months

XML

Accounting Policies, by Policy (Policies)

12 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]

Principles of Consolidation :
The consolidated financial statements include the accounts of Hickok Incorporated and its wholly-owned domestic subsidiaries. Significant intercompany transactions and balances have been eliminated in the financial statements.

New Accounting Pronouncements, Policy [Policy Text Block]

New Accounting Standards :
The Company did not incur any material impact to its financial condition or results of operations due to the adoption of any new accounting standards during the periods reported.
In May 2014, the FASB issued its final standard on the recognition of revenue from contracts with customers.  The standard, issued as Accounting Standards Update (ASU) 2014-09, outlines a single comprehensive model for entities to use in the accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry specific guidance. The core principle of this model is that “an entity recognizes revenue to depict the transfer of promised goods or services to a customer in an amount that reflects the consideration to which the entity expects to e entitled in exchange for those goods and services.” The update is effective for financial statement periods beginning after December 15, 2016, with early adoption prohibited. The Company has not determined the impact of this pronouncement on its financial statements and related disclosure.

Concentration Risk, Credit Risk, Policy [Policy Text Block]

Concentration of Credit Risk :
The Company sells its products and services primarily to customers in the United States of America and to a lesser extent overseas. All sales are made in United States of America dollars. The Company extends normal credit terms to its customers. Customers in the automotive industry comprise 87% of outstanding receivables at September 30, 2014 (60% in 2013). Sales to three customers approximated $2,768,000, $341,000 and $284,000 (2014), $2,304,000, $651,000 and $242,000 (2013), $905,000, $710,000 and $229,000 (2012), and accounts receivable to these customers amounted to approximately $731,000, $90,000 and $65,000 (2014), and $99,000, $163,000 and $14,000 (2013).

Use of Estimates, Policy [Policy Text Block]

Use of Estimates in the Preparation of Financial Statements :
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that may affect the reported amounts of certain assets and liabilities and disclosure of contingencies at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value of Financial Instruments:
Accounting for "Financial Instruments" requires the Company to disclose estimated fair values of financial instruments. Financial instruments held by the Company include, among others, accounts receivable, accounts payable, and convertible notes payable. The carrying amounts reported in the consolidated balance sheet for assets and liabilities qualifying as financial instruments is a reasonable estimate of fair value.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition :
The Company records sales as manufactured items are shipped to customers on an FOB shipping point arrangement, at which time title passes and the earnings process is complete. The Company primarily records service sales as the items are repaired. The customer does not have a right to return merchandise unless defective or warranty related and there are no formal customer acceptance provisions. Sales returns and allowances were immaterial during each of the three years in the period ending September 30, 2014.

Standard Product Warranty, Policy [Policy Text Block]

Product Warranties :
The Company warrants certain products against defects for periods ranging primarily from 12 to 48 months. The Company's estimated future warranty claims is included in "Accrued expenses" and are as follows:

	2014			2013			2012
Balance October 1	$	89		$	451		$	993
Current year provisions		10,275			8,690			7,564
Expenditures		(10,355	)		(9,052	)		(8,106	)
Balance September 30	$	9		$	89		$	451

Research, Development, and Computer Software, Policy [Policy Text Block]

Product Development Costs :
Product development costs, which include engineering production support, are expensed as incurred. Research and development performed for customers represents no more than 1% of sales in each year. The arrangements do not include a repayment obligation by the Company.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Cash Equivalents :
For purposes of the Statement of Cash Flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. From time to time the Company maintains cash balances in excess of the FDIC limits. The cash balance at September 30, 2014 and 2013 amounted to $390,327 and $938,852, respectively.

Receivables, Policy [Policy Text Block]

Accounts Receivable :
The Company establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

Inventory, Policy [Policy Text Block]

Inventories :
Inventories are valued at the lower of cost (first-in, first-out) or market and consist of:

	2014		2013
Raw materials and component parts	$	1,066,672	$	852,229
Work-in-process		521,424		590,687
Finished products		126,101		146,900
	$	1,714,197	$	1,589,816

Property, Plant and Equipment, Policy [Policy Text Block]

Property, Plant and Equipment :
Property, plant and equipment are carried at cost. Maintenance and repair costs are expensed as incurred. Additions and betterments are capitalized. The depreciation policy of the Company is generally as follows:

Class	Method	Estimated Useful Lives
Buildings	Straight-line	10	-	40	years
Machinery and equipment	Straight-line	3	-	10	years
Tools and dies	Straight-line		3		years

Depreciation amounted to $62,195 (2014), $64,186 (2013), and $86,257 (2012).

Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]

Valuation of Long-Lived Assets :
Long-lived assets such as property, plant and equipment and software are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. If the total of the expected future undiscounted cash flows is less than the carrying amount of the asset, a loss is recognized for the difference between the fair value and carrying value of the asset.

Shipping and Handling Cost, Policy [Policy Text Block]

Shipping and Handling Costs :
Shipping and handling costs are classified as cost of product sold.

Advertising Costs, Policy [Policy Text Block]

Advertising Costs :
Advertising costs are expensed as incurred and amounted to $9,017 (2014), $6,558 (2013) and $6,940 (2012).

Income Tax, Policy [Policy Text Block]

Income Taxes :
The provision for income taxes is determined using the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes represents income taxes paid or payable for the current year plus any change in deferred taxes during the year. Deferred taxes result from differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized.

Earnings Per Share, Policy [Policy Text Block]

Income per Common Share :
Income per common share information is computed on the weighted average number of shares outstanding during each period as disclosed in Note 10.

XML

Note 1 - Nature of Operations

12 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Nature of Operations [Text Block]

1. NATURE OF OPERATIONS

Hickok Incorporated and its wholly-owned domestic subsidiaries ("Company") develop and manufacture products used by companies in the transportation and emissions testing industries. Among the products are indicators and gauges sold to companies in aircraft and locomotive markets. On a much larger scale, the Company manufactures diagnostic equipment used by technicians to test the various electronic systems in automobiles and trucks, and emissions testing equipment specified by various states for testing vehicle emissions. The Company serves the automotive, locomotive and general aviation markets predominately in North America. Sales in the Company's principal product classes, as a percent of consolidated sales, are as follows:

Product Classes	2014			2012			2012
Automotive Test Equipment		76.3	%		74.4	%	66.1	%
Indicating Instruments		23.7			25.6		33.9
Total		100.0	%		100.0	%	100.0	%

Current operating properties consist of a manufacturing plant in Greenwood, Mississippi, and a corporate headquarters, marketing and product development facility in Cleveland, Ohio.

XML

Consolidated Balance Sheet (Parentheticals) (USD $)	Sep. 30, 2014	Sep. 30, 2013
Accounts receivable-less allowance for doubtful accounts (in Dollars)	$ 10,000	$ 10,000
Inventories-less allowance for obsolete inventory (in Dollars)	363,500	793,000
Deferred income taxes-less valuation allowance (in Dollars)	107,700	334,200
Deferred income taxes-less valuation allowance (in Dollars)	$ 4,059,000	$ 3,788,100
Preferred stock - par value (in Dollars per share)	$ 0	$ 0
Preferred stock - shares authorized	1,000,000	1,000,000
Preferred stock - shares outstanding	0	0
Common Class A [Member]
Class of common stock - par value (in Dollars per share)	$ 0	$ 0
Class of common stock - shares authorized	10,000,000	10,000,000
Class of common stock - shares outstanding	1,163,349	1,163,349
Treasury shares	15,795	15,795
Common Class B [Member]
Class of common stock - par value (in Dollars per share)	$ 0	$ 0
Class of common stock - shares authorized	2,500,000	2,500,000
Class of common stock - shares outstanding	475,533	475,533
Treasury shares	667	667

XML

Note 11 - Employee Benefit Plans

12 Months Ended

Sep. 30, 2014

Compensation and Retirement Disclosure [Abstract]

Pension and Other Postretirement Benefits Disclosure [Text Block]

11. EMPLOYEE BENEFIT PLANS 

The Company has a 401(k) Savings and Retirement Plan covering all full-time employees. Company contributions to the plan, including matching of employee contributions, are at the Company's discretion. For fiscal years ended September 30, 2014, 2013 and 2012, the Company made matching contributions to the plan in the amount of $16,979, $16,003 and $15,178, respectively. The Company does not provide any other postretirement benefits to its employees.

XML

Document And Entity Information (USD $)	12 Months Ended
	Sep. 30, 2014	Mar. 31, 2014	Jan. 02, 2015
Document Information [Line Items]
Entity Registrant Name	HICKOK INC
Document Type	10-K
Current Fiscal Year End Date	--09-30
Entity Public Float		$ 1,500,888
Amendment Flag	false
Entity Central Index Key	0000047307
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2014
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			1,163,349
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			474,866

XML

Note 12 - Segment and Related Information

12 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

12. SEGMENT AND RELATED INFORMATION 

The Company's four business units have a common management team and infrastructure. The indicators and gauges unit has different technologies and customers than the other business units. Therefore, the business units have been aggregated into two reportable segments: 1.) indicators and gauges and 2.) automotive related diagnostic tools and equipment. The Company's management evaluates segment performance based primarily on operating earnings before taxes. Non-operating items such as interest income and interest expense are included in general corporate expenses. Depreciation expense on assets used in manufacturing are considered part of each segment's operating performance. Depreciation expense on non-manufacturing assets is included in general corporate expenses.

Indicators and Gauges:
This segment consists of products manufactured and sold primarily to companies in the aircraft and locomotive industry. Within the aircraft market, the primary customers are those companies that manufacture or service business and pleasure aircraft. Within the locomotive market, indicators and gauges are sold to both original equipment manufacturers and to operators of railroad equipment.

Automotive Diagnostic Tools and Equipment:
This segment consists primarily of products designed and manufactured to support the testing or servicing of automotive systems using electronic means to measure vehicle parameters. These products are sold to OEMs and to the aftermarket using several brand names and a variety of distribution methods. Included in this segment are products used for state required testing of vehicle emissions.

Information by industry segment is set forth below: 

Years Ended September 30,	2014			2013			2012
Net Sales
Indicators and Gauges	$	1,492,348		$	1,657,725		$	1,612,943
Automotive Diagnostic Tools and Equipment		4,813,488			4,808,447			3,148,346
	$	6,305,836		$	6,466,172		$	4,761,289
Income (Loss) Before Provision for Income Taxes
Indicators and Gauges	$	312,692		$	433,361		$	271,343
Automotive Diagnostic Tools and Equipment		704,427			834,630			(78,433	)
General Corporate Expenses		(1,008,743	)		(1,129,186	)		(976,876	)
	$	8,376		$	138,805		$	(783,966	)

Asset Information : 

Years Ended September 30,	2014		2013
Identifiable Assets
Indicators and Gauges	$	685,198	$	898,555
Automotive Diagnostic Tools and Equipment		2,199,779		1,327,932
Corporate		814,680		1,278,196
	$	3,699,657	$	3,504,683

Geographical Information :
Included in the consolidated financial statements are the following amounts related to geographic locations:

Years Ended September 30,	2014		2013		2012
Revenue:
United States of America	$	6,149,883	$	6,317,722	$	4,598,029
Australia		64,744		23,481		14,018
Canada		58,983		77,239		72,535
Mexico		25,288		16,640		36,960
Taiwan		-		22,481		34,935
Other foreign countries		6,938		8,609		4,812
	$	6,305,836	$	6,466,172	$	4,761,289

All export sales to Australia, Canada, Mexico, Taiwan and other foreign countries are made in United States of America Dollars.

XML

Consolidated Statement of Income (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
NET SALES:
Product sales	$ 6,078,349	$ 6,190,260	$ 4,442,133
Service sales	227,487	275,912	319,156
Total Net Sales	6,305,836	6,466,172	4,761,289
COSTS AND EXPENSES:
Cost of product sold	3,462,092	3,359,727	2,787,212
Cost of services sold	149,068	138,307	216,949
Product development	965,975	939,373	938,058
Marketing and administrative expenses	1,728,107	1,812,598	1,616,320
Interest charges	6,592	91,178	5,956
Other income	(14,374)	(13,816)	(19,240)
Total Costs and Expenses	6,297,460	6,327,367	5,545,255
Income (Loss) before Provision for Income Taxes	8,376	138,805	(783,966)
Provision For Income Taxes:
Current	(44,400)	114,400
Deferred	44,400	(114,400)
	0	0	0
Net Income (Loss)	$ 8,376	$ 138,805	$ (783,966)
NET Income (LOSS) PER COMMON SHARE - BASIC (in Dollars per share)	$ 0.01	$ 0.09	$ (0.57)
NET Income (LOSS) PER COMMON SHARE - DILUTED (in Dollars per share)	$ 0.01	$ 0.08	$ (0.57)
WEIGHTED AVERAGE SHARES OF COMMON STOCK OUTSTANDING (in Shares)	1,638,215	1,610,571	1,372,812

XML

Note 6 - Leases

12 Months Ended

Sep. 30, 2014

Leases [Abstract]

Leases of Lessee Disclosure [Text Block]

6. LEASES 

Operating :
The Company leases a facility and certain equipment under operating leases expiring through September 2016.

The Company's minimum commitment under these operating leases is as follows:

2015	$	6,866
2016		2,880
2017		-
Total	$	9,746

Rental expense under these commitments was $10,521 (2014), $10,444 (2013) and $7,971 (2012).

A facility held under a capital lease has a net book value of $0 at September 30, 2014. Future minimum lease payments which extend through 2061 are immaterial.

XML

Note 5 - Short-term Financing

12 Months Ended

Sep. 30, 2014

Disclosure Text Block [Abstract]

Short-term Debt [Text Block]

5. SHORT-TERM FINANCING

The Company had a credit agreement of $250,000 with Robert L. Bauman, one of its major shareholders who is also an employee of the Company. The agreement was to expire in April 2013 but was modified on December 31, 2012 to extend the maturity date to December 2013. Effective October 30, 2012 for the remainder of the agreement, the lender could have terminated the agreement with 45 days written notice, and at the discretion of the Company to deny the termination notice until December 2013 if it would have had a negative effect on the solvency of the Company.

The agreement provided for a revolving credit facility of $250,000 with interest at 0.24% per annum and was unsecured and included a three-year warrant for 100,000 shares of Class A common stock at a price of $2.50 per share. In addition, the agreement generally allowed for borrowing based on an amount equal to eighty percent of eligible accounts receivables or $250,000. The revolving line of credit was not extended.

In partial consideration for the original extension of the revolving credit facility the Company and Bauman entered into a Warrant Agreement, dated December 30, 2012 whereby the Company issued a warrant to Bauman to purchase, at his option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued was amortized over the one-year credit agreement period. During fiscal year ended September 30, 2013, $45,500 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the fiscal year ended September 30, 2013: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

During the fiscal year ended September 30, 2014, the Company entered into various short-term unsecured demand notes with Robert L. Bauman borrowing a total of $683,400 with interest at 4.0%. The Company recorded interest expense of $6,364 for fiscal 2014 and $75 for fiscal 2013. As of September 30, 2014, $6,174 of interest was paid on the above notes and line of credit. The Company had no outstanding borrowings on the various short-term demand notes at September 30, 2014.

Selected details of short-term borrowings for fiscal 2014 and 2013 are as follows:

	Amount		Weighted Average Interest Rate
Balance at September 30, 2014	$	-		4.00	%
Average during 2014	$	151,133		4.00	%
Maximum during 2014 (month end)	$	683,400		4.00	%
Balance at September 30, 2013	$	-		.24	%
Average during 2013	$	29,167		.24	%
Maximum during 2013 (month end)	$	250,000		.24	%

XML

Schedule II - Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2014

Valuation and Qualifying Accounts [Abstract]

Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

HICKOK INCORPORATED

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
 

Col. A	Col. B	Col. C		Col. D	Col. E
		Additions
	Balance at	Charged to	Charged to		Balance
	Beginning	Costs and	Other		at End
Description	of Period	Expenses	Accounts	Deductions	of Period
Deducted from Asset Accounts:
		Year Ended September 30, 2012

Reserve for doubtful accounts	$	10,000	$	374	(1)	$	-	(2)	$	374	(3)	$	10,000
Reserve for inventory obsolescence	$	714,000	$	185,697		$	-		$	48,697	(4)	$	851,000
Reserve for product warranty	$	993	$	7,565		$	-		$	8,107		$	451
Valuation allowance deferred taxes	$	4,049,300	$	187,400		$	-		$	-		$	4,236,700

Year Ended September 30, 2013

Reserve for doubtful accounts	$	10,000	$	2,049	(1)	$	-	(2)	$	2,049	(3)	$	10,000
Reserve for inventory obsolescence	$	851,000	$	60,107		$	-		$	118,107	(4)	$	793,000
Reserve for product warranty	$	451	$	8,690		$	-		$	9,052		$	89
Valuation allowance deferred taxes	$	4,236,700	$	-		$	-		$	114,400		$	4,122,300

Year Ended September 30, 2014

Reserve for doubtful accounts	$	10,000	$	(4,446	)(1)	$	-	(2)	$	(4,446	)(3)	$	10,000
Reserve for inventory obsolescence	$	793,000	$	(113,603	)	$	-		$	315,897	(4)	$	363,500
Reserve for product warranty	$	89	$	10,275		$	-		$	10,335		$	9
Valuation allowance deferred taxes	$	4,122,300	$	44,400		$	-		$	-		$	4,166,700

(1)  Classified as bad debt expense.

(2)  Recoveries on accounts charged off in prior years.

(3)  Accounts charged off during year as uncollectible.

(4)  Inventory charged off during the year as obsolete.

XML

Note 13 - Commitments and Contingencies

12 Months Ended

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

13. COMMITMENTS AND CONTINGENCIES

Legal Matters:

The Company is the plaintiff in a suit pursuing patent infringement against a competitor in the emissions market. Management believes that it is not currently possible to estimate the impact, if any, that the ultimate resolution of this matter will have on the Company's results of operations, financial position or cash flows.

XML

Note 9 - Income Taxes

12 Months Ended

Sep. 30, 2014

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

9. INCOME TAXES 

A reconciliation of the provision (recovery) of income taxes to the statutory federal income tax rate is as follows:

	2014			2013			2012
Income (Loss) Before Provision for Income Taxes	$	8,376		$	138,805		$	(783,966	)
Statutory rate		34	%		34	%		34	%
		2,848			47,194			(266,548	)
Permanent differences		1,200			1,200			2,500
Research and development credit - net		(46,300	)		(44,900	)		(8,500	)
Valuation allowance		44,400			-			274,600
Other		(2,148	)		(3,494	)		(2,052	)
	$	-		$	-		$	-

Deferred tax assets (liabilities) consist of the following:

	2014			2013
Current:
Inventories	$	128,900		$	277,300
Bad debts		3,400			3,400
Accrued liabilities		(11,700	)		63,000
Prepaid expense		(12,900	)		(9,500	)
		107,700			334,200
Valuation allowance		(107,700	)		(334,200	)
Total current deferred income taxes		-			-
Noncurrent:
Depreciation and amortization		45,100			42,700
Research and development and other credit carryforwards		1,903,800			1,830,600
Net operating loss carryforward		1,880,200			1,817,200
Contribution carryforward		8,900			8,900
Directors stock option plan		40,000			39,000
Acquisition costs		101,000			49,700
Accrued liabilities		80,000			-
		4,059,000			3,788,100
Valuation allowance		(4,059,000	)		(3,788,100	)
Total long-term deferred income taxes		-			-
Total	$	-		$	-

The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

The Company is subject to U.S federal jurisdiction income tax examinations for the tax years 2010 through 2012. In addition, the Company is subject to state and local income tax examinations for the tax years 2010 through 2012.

The Company has available a net operating loss carryforward of approximately $5,500,000, and a research and development credit carryforward of approximately $1,800,000, and a contribution carryforward of approximately $26,000. The net operating loss, research and development credit and contribution carryforwards will begin to expire in fiscal 2025, 2016, and 2015 respectively.

Management has recorded a valuation allowance on the entire balance of deferred tax assets due to the losses during the past several years, the current economic uncertainties, the negative effects of the recent economic crisis on all the Company's markets and concern that a more likely than not expiration of the Company's net operating loss, research and development credit and contribution carryforwards could occur before they can be used.

The Company's ability to realize the entire benefit of its deferred tax assets requires that the Company achieve certain future earning levels prior to the expiration of its net operating loss, research and development credit and contribution carryforwards. Because of the uncertainties involved with this significant estimate, it is reasonably possible that the Company's estimate may change in the near term.

XML

Note 12 - Segment and Related Information (Details) - Asset Information (USD $)	Sep. 30, 2014	Sep. 30, 2013
Identifiable Assets
Identifiable assets	$ 3,699,657	$ 3,504,683
Indicators and Gauges [Member]
Identifiable Assets
Identifiable assets	685,198	898,555
Automotive Diagnostic Tools and Equipment [Member]
Identifiable Assets
Identifiable assets	2,199,779	1,327,932
Corporate, Non-Segment [Member]
Identifiable Assets
Identifiable assets	$ 814,680	$ 1,278,196

XML

Note 7 - Stock Options

12 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

7. STOCK OPTIONS 

On February 27, 2013, the Company's 2013 Omnibus Equity Plan was approved and adopted by an affirmative vote of a majority of the Company's Class A and Class B Shareholders.

The 2013 Omnibus Plan will provide the Company with the flexibility to grant a variety of share-based awards for covered employees, consultants and Directors. The 2013 Omnibus Plan provides for the grant of the following types of incentive awards: stock options, stock appreciation rights, restricted shares, restricted share units, performance shares and Class A Common Shares. Those who will be eligible for awards under the 2013 Omnibus Plan include employees who provide services to the Company and its affiliates, executive officers, non-employee Directors and consultants designated by the Compensation Committee. The Plan has 150,000 Class A Common Shares reserved for issuance. The Class A Common Shares may be either authorized, but unissued, common shares or treasury shares. No share-based awards have been granted under the 2013 Omnibus Equity Plan as of September 30, 2014.

Under the Company's expired Key Employees Stock Option Plans there are no options currently available for grant and there are no options outstanding at September 30, 2014.

The Company's expired Outside Directors Stock Option Plans (collectively the "Directors Plans"), have provided for the automatic grant of options to purchase up to 22,000 shares of Class A Common Stock over a three-year period to members of the Board of Directors who were not employees of the Company, at the fair market value on the date of grant. The options are exercisable for up to 10 years. All options granted under the Directors Plans become fully exercisable on March 8, 2015.

Non-cash compensation expense related to stock option plans for fiscal years ended September 30, 2014, 2013 and 2012 was $2,837, $6,465 and $11,388 respectively.

Transactions involving the Directors Plans are summarized as follows: 

				Weighted Average Exercise					Weighted Average Exercise					Weighted Average Exercise
	2014			Price		2013			Price		2012			Price
Option Shares Directors Plans:
Outstanding October 1,		31,000		$	5.57		42,000		$	5.62		38,000		$	5.95
Granted		-			-		-			-		7,000			2.925
Canceled/expired		(9,000	)		6.23		(11,000	)		3.55		(3,000	)		3.55
Exercised		-			-		-			-		-			-
Outstanding September 30, ($2.925 to $11.00 per share)		22,000			5.30		31,000			5.57		42,000			5.62
Exercisable September 30,		20,000			5.54		25,000			6.20		30,000			6.52

The following is a summary of the range of exercise prices for stock options outstanding and exercisable under the Directors Plans at September 30, 2014.

Directors Plans			Outstanding Stock Options		Weighted Average Exercise Price		Weighted Average Remaining Life		Number of Stock Options Exercisable		Weighted Average Exercise Price
Range of exercise prices:
$2.925	-	5.25		13,000	$	3.28		5.9		11,000	$	3.35
$6.00	-	7.25		5,000	$	6.18		3.5		5,000	$	6.18
$10.50	-	11.00		4,000	$	10.75		3.0		4,000	$	10.75
				22,000	$	5.30				20,000	$	5.54

The Company accounts for Share-Based Payments under the modified prospective method for its stock options. Compensation cost for fixed based awards is measured at the grant date, and the Company uses the Black-Scholes option pricing model to determine the fair value estimates for recognizing the cost of employee and director services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. Director's stock options under the expired Outside Directors Stock Option Plans are exercisable over a three year period. The fair value of stock option grants to Directors is amortized over the three-year vesting period. During fiscal year ended September 30, 2014 and 2013, $2,837 and $6,465, respectively, was expensed as share-based compensation. Total compensation costs related to nonvested awards not yet recognized is $543 (2015). The following weighted-average assumptions were used in the option pricing model for 2014 and 2013: a risk free interest rate of 5.0% and 5.0%; an expected life of 10 and 10 years; an expected dividend yield of 0.0% and 0.0%; and a volatility factor of .87 and .87.

XML

Note 8 - Capital Stock, Treasury Stock, and Contributed Capital

12 Months Ended

Sep. 30, 2014

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]

8. CAPITAL STOCK, TREASURY STOCK, AND CONTRIBUTED CAPITAL 

On October 11, 2012, the Company's Amended Articles of Incorporation and the Amended Code of Regulations were adopted by an affirmative vote of more than two-thirds of the Company's Class A and Class B Shareholders.

The Amended Articles amend and restate the Current Articles in a number of significant ways and are primarily as follows: increased the number of Class A Shares and Class B Shares from 3,750,000 and 1,000,000 to 10,000,000 and 2,500,000 respectively, and added a class of 1,000,000 Serial Preferred Shares; eliminated par value for Class A Shares and Class B Shares; updated certain provisions relating to the payment of dividends; removed restrictions on the issuance of additional Class A Shares; clarified the method by which the Company may repurchase its shares; reduced the percentage of shareholder vote required to authorize corporate actions from two-thirds of the voting power to a majority of the voting power; and made other technical or conforming changes.

The Amended Regulations amend and restate the Current Regulations in a number of significant ways and are primarily as follows: updated certain provisions relating to the Company's meetings of shareholders in order to provide more consistency in the regulations regarding the Company's practices in this area; further clarifying the roles of the Company's officers and directors in conducting the Company's business; updated the Company's policy regarding the indemnification of its directors, officers, employees, and others; revised provisions allowing for the Board of Directors to adopt amendments to the Amended Regulations to the extent permitted by Ohio law; and made other technical or conforming changes.

Unissued shares of Class A common stock (949,233 and 958,233 shares in 2014 and 2013, respectively) are reserved for the share-for-share conversion rights of the Class B common stock, stock options under the Directors Plans, conversion rights of the Convertible Promissory Note and available warrants (see Notes 4, 5 and 7). The Class A shares have one vote per share and the Class B shares have three votes per share, except under certain circumstances such as voting on voluntary liquidation, sale of substantially all the assets, etc. Dividends up to $.10 per year, noncumulative, must be paid on Class A shares before any dividends are paid on Class B shares.

XML

Note 10 - Earnings Per Common Share

12 Months Ended

Sep. 30, 2014

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

10. EARNINGS PER COMMON SHARE 

The following table sets forth the computation of basic and diluted earnings per share.

	2014		2013		2012
Basic Income (Loss) Per Share
Income (Loss) available to common stockholders	$	8,376	$	138,805	$	(783,966	)
Shares denominator		1,638,215		1,610,571		1,372,812
Per share amount	$	.01	$	.09	$	(.57	)
Effect of Dilutive Securities
Average shares outstanding		1,638,215		1,610,571		1,372,812
Options available under convertible note		31,097		23,505		-
		1,669,312		1,634,076		1,372,812
Diluted Income (Loss) Per Share
Income (Loss) available to common stockholders	$	8,376	$	138,805	$	(783,966	)
Per share amount	$	.01	$	.08	$	(.57	)

Options and warrants to purchase 22,000 and 200,000 shares of common stock respectively during fiscal 2014 at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In fiscal 2013 options and warrants to purchase 31,000 and 200,000 shares of common stock respectively at prices ranging from $2.50 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's and warrant's effect was antidilutive or the exercise price was greater than the average market price of the common share.

In fiscal 2012 options to purchase 42,000 shares of common stock at prices ranging from $2.925 to $11.00 per share were outstanding but were not included in the computation of diluted earnings per share because the option's effect was antidilutive or the exercise price was greater than the average market price of the common share. In addition, conversion rights to purchase 365,119 shares of common stock at a price of $1.85 per share were not included in the computation of diluted earnings per share because the conversion rights of the Convertible Promissory Notes effect was antidilutive.

XML

Schedule II - Valuation and Qualifying Accounts (Details) - Summary of Valuation and Qualifying Accounts (USD $)	12 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2012
Allowance for Doubtful Accounts [Member]
Schedule II - Valuation and Qualifying Accounts (Details) - Summary of Valuation and Qualifying Accounts [Line Items]
Beginning balance	$ 10,000		$ 10,000		$ 10,000
Charged to costs and expenses	(4,446)		2,049	[1]	374	[1]
Charged to other accounts		[2]		[2]		[2]
Deductions	(4,446)		2,049	[3]	374	[3]
Ending balance	10,000		10,000		10,000
Inventory Valuation Reserve [Member]
Schedule II - Valuation and Qualifying Accounts (Details) - Summary of Valuation and Qualifying Accounts [Line Items]
Beginning balance	793,000		851,000		714,000
Charged to costs and expenses	(113,603)		60,107		185,697
Deductions	315,897	[4]	118,107	[4]	48,697	[4]
Ending balance	363,500		793,000		851,000
Warranty Reserves [Member]
Schedule II - Valuation and Qualifying Accounts (Details) - Summary of Valuation and Qualifying Accounts [Line Items]
Beginning balance	89		451		993
Charged to costs and expenses	10,275		8,690		7,565
Deductions	10,335		9,052		8,107
Ending balance	9		89		451
Valuation Allowance of Deferred Tax Assets [Member]
Schedule II - Valuation and Qualifying Accounts (Details) - Summary of Valuation and Qualifying Accounts [Line Items]
Beginning balance	4,122,300		4,236,700		4,049,300
Charged to costs and expenses	44,400				187,400
Deductions			114,400
Ending balance	$ 4,166,700		$ 4,122,300		$ 4,236,700

[1] Classified as bad debt expense.

[2] Recoveries on accounts charged off in prior years.

[3] Accounts charged off during year as uncollectible.

[4] Inventory charged off during the year as obsolete.

XML

Note 16 - Quarterly Data (Unaudited) (Details) - Summary of Quarterly Data (Unaudited) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Net Sales
Net sales	$ 6,305,836	$ 6,466,172	$ 4,761,289
Net Income (Loss)
Net income (loss)	8,376	138,805	(783,966)
Basic
Net income (loss) per common share, basic (in Dollars per share)	$ 0.01	$ 0.09	$ (0.57)
Diluted
Net income (loss) per common share, diluted (in Dollars per share)	$ 0.01	$ 0.08	$ (0.57)
First [Member]
Net Sales
Net sales	1,050,242	1,738,903	1,181,501
Gross Profit
Gross profit	360,838	812,501	392,712
Net Income (Loss)
Net income (loss)	(320,287)	143,804	(183,140)
Basic
Net income (loss) per common share, basic (in Dollars per share)	$ (0.20)	$ 0.09	$ (0.15)
Diluted
Net income (loss) per common share, diluted (in Dollars per share)	$ (0.20)	$ 0.09	$ (0.15)
Second [Member]
Net Sales
Net sales	1,116,467	1,964,338	1,178,538
Gross Profit
Gross profit	428,031	856,177	402,681
Net Income (Loss)
Net income (loss)	(297,655)	119,431	(224,781)
Basic
Net income (loss) per common share, basic (in Dollars per share)	$ (0.18)	$ 0.08	$ (0.16)
Diluted
Net income (loss) per common share, diluted (in Dollars per share)	$ (0.18)	$ 0.07	$ (0.16)
Third [Member]
Net Sales
Net sales	2,130,412	1,339,931	1,271,803
Gross Profit
Gross profit	1,124,914	572,192	479,189
Net Income (Loss)
Net income (loss)	386,911	(133,777)	(170,975)
Basic
Net income (loss) per common share, basic (in Dollars per share)	$ 0.24	$ (0.08)	$ (0.12)
Diluted
Net income (loss) per common share, diluted (in Dollars per share)	$ 0.23	$ (0.08)	$ (0.12)
Fourth [Member]
Net Sales
Net sales	2,008,715	1,423,000	1,129,447
Gross Profit
Gross profit	780,893	727,268	482,546
Net Income (Loss)
Net income (loss)	$ 239,407	$ 9,347	$ (205,070)
Basic
Net income (loss) per common share, basic (in Dollars per share)	$ 0.15	$ 0.01	$ (0.14)
Diluted
Net income (loss) per common share, diluted (in Dollars per share)	$ 0.14	$ 0.01	$ (0.14)

XML

Note 16 - Quarterly Data (Unaudited) (Tables)

12 Months Ended

Sep. 30, 2014

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information [Table Text Block]

	First			Second			Third			Fourth
Net Sales
2014	$	1,050,242		$	1,116,467		$	2,130,412		$	2,008,715
2013		1,738,903			1,964,338			1,339,931			1,423,000
2012		1,181,501			1,178,538			1,271,803			1,129,447
Gross Profit
2014		360,838			428,031			1,124,914			780,893
2013		812,501			856,177			572,192			727,268
2012		392,712			402,681			479,189			482,546
Net Income (Loss)
2014		(320,287	)		(297,655	)		386,911			239,407
2013		143,804			119,431			(133,777	)		9,347
2012		(183,140	)		(224,781	)		(170,975	)		(205,070	)
Net Income (Loss) per Common Share
Basic
2014		(.20	)		(.18	)		.24			.15
2013		.09			.08			(.08	)		.01
2012		(.15	)		(.16	)		(.12	)		(.14	)
Diluted
2014		(.20	)		(.18	)		.23			.14
2013		.09			.07			(.08	)		.01
2012		(.15	)		(.16	)		(.12	)		(.14	)

XML

Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) (USD $)	Oct. 11, 2012	Sep. 30, 2014	Sep. 30, 2013
Common Class A [Member] | Original Authorized Shares [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized	3,750,000
Common Class A [Member] | Current Authorized Shares [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized	10,000,000
Common Class A [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized		10,000,000	10,000,000
Common Stock, Capital Shares Reserved for Future Issuance		949,233	958,233
Dividends Payable, Amount Per Share (in Dollars per share)		$ 0.10
Common Class B [Member] | Original Authorized Shares [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized	1,000,000
Common Class B [Member] | Current Authorized Shares [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized	2,500,000
Common Class B [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized		2,500,000	2,500,000
Serial Preferred Shares [Member]
Note 8 - Capital Stock, Treasury Stock, and Contributed Capital (Details) [Line Items]
Common Stock, Shares Authorized	1,000,000

XML

Note 15 - Business Condition and Management Plan

12 Months Ended

Sep. 30, 2014

Going Concern Disclosure [Abstract]

Going Concern Disclosure [Text Block]

15. BUSINESS CONDITION AND MANAGEMENT PLAN

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has suffered recurring losses from operations during the past several years due primarily to decreasing sales of existing product lines and a general economic downturn in all markets the Company serves. The resulting lower sales levels have impacted the Company's accounts receivable and cash balances, if this situation continues it may prevent the Company from generating sufficient cash flow to sustain its operations.

The ability of the Company to continue as a going concern is dependent on improving the Company's profitability and cash flow and securing additional financing if needed. Management continues to review and revise its strategic plan and believes in the viability of its strategy to increase revenues and profitability through increased sales of existing products and the introduction of new products to the market place. Management believes that the actions presently being taken by the Company will provide the stimulus for it to continue as a going concern, however, because of the inherent uncertainties there can be no assurances to that effect. These consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Additionally, the Company has net operating loss carryforwards, currently valued at $0, that offset taxable income.

In addition, on December 31, 2014, management entered into an amended unsecured convertible loan agreement which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The unsecured convertible loan agreement is with a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement and continues to allow $250,000 of borrowing on the agreement at the Company's discretion. This facility is available through December 2015. The Company has borrowed $200,000 on the loan agreement during the year and it is outstanding at September 30, 2014.

Management’s strategic plan to increase revenues and profitability through increased sales of existing products, the introduction of new products to the market place and the cash generated from the completion of the large order from a Tier 1 Supplier during the current fiscal year should provide the Company with the needed working capital for the next twelve months.

XML

Note 2 - Summary of Significant Accounting Policies (Tables)

12 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Allowance for Credit Losses on Financing Receivables [Table Text Block]

	2014			2013			2012
Balance October 1	$	89		$	451		$	993
Current year provisions		10,275			8,690			7,564
Expenditures		(10,355	)		(9,052	)		(8,106	)
Balance September 30	$	9		$	89		$	451

Schedule of Inventory, Current [Table Text Block]

	2014		2013
Raw materials and component parts	$	1,066,672	$	852,229
Work-in-process		521,424		590,687
Finished products		126,101		146,900
	$	1,714,197	$	1,589,816

Property, Plant and Equipment [Table Text Block]

Class	Method	Estimated Useful Lives
Buildings	Straight-line	10	-	40	years
Machinery and equipment	Straight-line	3	-	10	years
Tools and dies	Straight-line		3		years

XML

Note 7 - Stock Options (Details) - Transactions Involving the Directors Plans (Parentheticals) (USD $)	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2012
Note 7 - Stock Options (Details) - Transactions Involving the Directors Plans (Parentheticals) [Line Items]
Exercise Price Range, Low	$ 2.925	$ 2.925	$ 2.925
Exercise Price Range, High	$ 11.00	$ 11.00	$ 11.00

XML

Note 3 - Notes Receivable (Details) - Summary of Notes Receivable (Parentheticals) (Current Employee [Member])	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Related Party Transaction [Line Items]
Unsеcurеd notе rеcеivablе intеrеst pеr annum	3.00%	3.00%
Current Portion [Member]
Related Party Transaction [Line Items]
Unsеcurеd notе rеcеivablе intеrеst pеr annum	3.00%

XML

Consolidated Statement of Stockholders' Equity (USD $)	Common Class A [Member] Common Stock [Member]	Common Class B [Member] Common Stock [Member]	Retained Earnings [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Total
Balance at October 1, 2011 at Sep. 30, 2011	$ 793,229	$ 454,866	$ 171,738	$ 1,862,652	$ (661,676)	$ 2,620,809
Sale of Class B shares from treasury		20,000		(391,335)	408,335	37,000
Conversion of convertible notes payable to Class A shares	252,368			214,511		466,879
Convertible notes issue cost				(34,235)		(34,235)
Share-based compensation expense				11,388		11,388
Net Income (loss)			(783,966)			(783,966)
Balance at Sep. 30, 2012	1,045,597	474,866	(612,228)	1,662,981	(253,341)	2,317,875
Balance at October 1, 2011 at Sep. 30, 2012
Fees for additional authorized Class A, Class B and Preferred shares				(21,925)		(21,925)
Conversion of convertible notes payable to Class A shares	208,591					208,591
Class A shares issued for professional services	7,000					7,000
Warrants issued for debt offering				91,000		91,000
Share-based compensation expense				6,465		6,465
Net Income (loss)			138,805			138,805
Balance at Sep. 30, 2013	1,261,188	474,866	(473,423)	1,738,521	(253,341)	2,747,811
Balance at October 1, 2011 at Sep. 30, 2013
Share-based compensation expense				2,837		2,837
Net Income (loss)			8,376			8,376
Balance at Sep. 30, 2014	$ 1,261,188	$ 474,866	$ (465,047)	$ 1,741,358	$ (253,341)	$ 2,759,024

XML

Note 4 - Convertible Notes Payable

12 Months Ended

Sep. 30, 2014

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

4. CONVERTIBLE NOTES PAYABLE

On December 30, 2011, Hickok Incorporated entered into a Convertible Loan Agreement with Roundball, LLC and the Aplin Family Trust. Under the Convertible Loan Agreement, the Company issued a convertible note to Roundball in the amount of $466,879 and a convertible note to the Aplin Family Trust in the amount of $208,591. In addition, Roundball, LLC had the right to cause the Company to borrow up to an additional $466,880 from Roundball, LLC. The notes were unsecured, bore interest at a rate of 0.20% per annum and were set to mature on December 30, 2012.

The notes were convertible by the Investors at any time into Class A Common Shares of the Company, at a conversion price of $1.85 per share, although up to no more than 504,735 Conversion Shares for Roundball and no more than 112,752 Conversion Shares for the Aplin Family Trust. The Company had the option to convert the notes at the expiration date, if the investors had not during the course of the agreement. On December 30, 2011, Roundball converted $233,438 into Class A Common Shares of the Company. In addition, on August 20, 2012 Roundball converted the remaining $233,441 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 28, 2012, the Aplin Family Trust converted the $208,591 under the Convertible Loan Agreement into Class A Common Shares of the Company.

On December 30, 2012, management entered into an amended Convertible Loan Agreement with Roundball which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement was by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2012 to December 30, 2013 and modified the terms to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.24%.

In partial consideration for Amendment No. 1, the Company and Roundball entered into a Warrant Agreement, dated December 30, 2012, whereby the Company issued a warrant to Roundball to purchase, at its option, up to 100,000 shares of Class A Common Stock of the Company at an exercise price of $2.50 per share, subject to certain anti-dilution and other adjustments. If not exercised, this warrant will expire on December 30, 2015. Roundball is an affiliate of Steven Rosen, a Director of the Company.

The Company used the Black-Scholes option pricing model to determine the fair value estimate for recognizing the cost of services received in exchange for an award of equity instruments. The Black-Scholes option pricing model requires the use of subjective assumptions which can materially affect the fair value estimates. The warrants are immediately exercisable and expire in December 2015. The fair value of the warrants issued was amortized over the one-year amended convertible loan agreement period. During fiscal year ended September 30, 2013, $45,500 was expensed as non-cash interest expense. The following weighted-average assumptions were used in the option pricing model for the fiscal year ended September 30, 2013: a risk free interest rate of 0.42%; an expected life of 3 years; an expected dividend yield of 0.0%; and a volatility factor of .84.

On December 30, 2013, management entered into Amendment No. 2 of the Convertible Loan Agreement with Roundball which continued to provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2013 to December 30, 2014 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.25%.

During fiscal year ended September 30, 2014, the Company borrowed $200,000 against this agreement. As of September 30, 2014, the outstanding balance on the Roundball convertible note was $200,000.

On December 31, 2014, management entered into Amendment No. 3 of the Convertible Loan Agreement with Roundball which continues to provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2014 to December 30, 2015 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.34%.

The Company recorded interest expense on the Roundball and Aplin Family Trust notes of $228 and $0 respectively for fiscal 2014, $0 and $103 respectively for fiscal 2013, and $303 and $314 respectively for fiscal 2012. As of September 30, 2014 no interest was paid.

XML

Note 12 - Segment and Related Information (Details)	12 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]
Number of Operating Segments	4
Number of Reportable Segments	2

XML

Note 3 - Notes Receivable (Tables)

12 Months Ended

Sep. 30, 2014

Receivables [Abstract]

Schedule of Related Party Transactions [Table Text Block]

	Current Portion		Total
	2014		2014		2013
Unsecured note receivable from current employee which bears interest at 3% per annum	$	-	$	4,100	$	4,100
	$	-		4,100		4,100
Less current portion				-		-
Long-term portion			$	4,100	$	4,100

XML

Note 2 - Summary of Significant Accounting Policies (Details) - Inventories Summary (USD $)	Sep. 30, 2014	Sep. 30, 2013
Inventories Summary [Abstract]
Raw materials and component parts	$ 1,066,672	$ 852,229
Work-in-process	521,424	590,687
Finished products	126,101	146,900
	$ 1,714,197	$ 1,589,816

XML

Note 14 - Subsequent Events

12 Months Ended

Sep. 30, 2014

Subsequent Events [Abstract]

Subsequent Events [Text Block]

14. SUBSEQUENT EVENTS

The Company has analyzed its operations subsequent to September 30, 2014 through the date the financial statements were submitted to the Securities and Exchange Commission, and has determined that no subsequent events have occurred that would require recognition in the consolidated financial statements or disclosure in the notes to the consolidated financial statements, except as follows:

On December 31, 2014, management entered into an amended Convertible Loan Agreement which may provide approximately $467,000 of liquidity to meet on going working capital requirements. The amended Convertible Loan Agreement is by and between the Company and a major shareholder who is also a Director modifying the terms and extending the due date of the loan agreement from December 30, 2014 to December 30, 2015 and continues to allow $250,000 of borrowing on the agreement at the Company's discretion at an interest rate of 0.34% per annum.

In addition, the Company's legal firm handling the patent infringement case discussed in Note 13 to the Company's financial statements has provided a letter indicating the firm will not seek to be paid by the Company prior to February 1, 2016, unbilled legal fees in excess of $45,000 unless the Lawsuit is settled prior to February 1, 2016.

Lastly, in December 2014, the Company issued a non-binding proposal letter to acquire the membership interests of Federal Hose LLC, a wholly owned subsidiary of First Francis Company, Inc. First Francis is owned by certain directors of the Company and the terms of the potential transaction are still being negotiated.